<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Hereditary stomatocytosis (HSt) and hereditary xerocytosis (HX)</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Hereditary stomatocytosis (HSt) and hereditary xerocytosis (HX)</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Hereditary stomatocytosis (HSt) and hereditary xerocytosis (HX)</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carlo Brugnara, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Immacolata Andolfo, PhD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert T Means, Jr, MD, MACP</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wilma Barcellini, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jennifer S Tirnauer, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 31, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1905391229"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Hereditary stomatocytosis (HSt) and hereditary xerocytosis (HX) are rare disorders that cause variable hemolytic anemia and abnormal red blood cell (RBC) morphologies. Both are disorders of RBC hydration. </p><p>This topic discusses the mechanisms, evaluation, and management of stomatocytosis and xerocytosis.</p><p>Separate topics discuss general approaches evaluating hereditary hemolytic anemias:</p><p class="bulletIndent1"><span class="glyph">●</span>Anemia (child) – (See  <a class="medical medical_review" href="/z/d/html/5927.html" rel="external">"Approach to the child with anemia"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Anemia (adult) – (See  <a class="medical medical_review" href="/z/d/html/7133.html" rel="external">"Diagnostic approach to anemia in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Elliptocytosis – (See  <a class="medical medical_review" href="/z/d/html/7087.html" rel="external">"Hereditary elliptocytosis and related disorders"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Spherocytosis – (See  <a class="medical medical_review" href="/z/d/html/7079.html" rel="external">"Hereditary spherocytosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Schistocytes – (See  <a class="medical medical_review" href="/z/d/html/7168.html" rel="external">"Non-immune (Coombs-negative) hemolytic anemias in adults", section on 'Fragmentation'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Target cells, burr cells, and spur cells – (See  <a class="medical medical_review" href="/z/d/html/7088.html" rel="external">"Burr cells, acanthocytes, and target cells: Disorders of red blood cell membrane"</a>.)</p><p></p><p class="headingAnchor" id="H1905391397"><span class="h1">DEFINITIONS AND CLASSIFICATION</span><span class="headingEndMark"> — </span>Stomatocyte and xerocyte are morphologic terms that describe the appearance of red blood cells (RBCs) on the peripheral blood smear. </p><p class="bulletIndent1"><span class="glyph">●</span>Stomatocytes (also called hydrocytes) contain a mouth-shaped area of central pallor on a stained blood smear  (<a class="graphic graphic_picture graphicRef75535" href="/z/d/graphic/75535.html" rel="external">picture 1</a>) and by scanning electron microscopy  (<a class="graphic graphic_picture graphicRef130751" href="/z/d/graphic/130751.html" rel="external">picture 2</a>). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Xerocytes (also called dessicocytes) are markedly hyperchromic RBCs  (<a class="graphic graphic_picture graphicRef62761" href="/z/d/graphic/62761.html" rel="external">picture 3</a>). </p><p></p><p>These morphologic changes imply a pathophysiologic process. (See <a class="local">'Pathophysiology'</a> below.)</p><p>Hereditary stomatocytosis (HSt) and hereditary xerocytosis (HX) are autosomal-dominant inherited conditions with variable hemolysis and anemia [<a href="#rid1">1</a>]. In dehydrated HSt (also called stomatocytic xerocytosis) both abnormalities may be seen. Some syndromes with HSt cannot readily be distinguished from HX, and several intermediate forms exist. The traditional classifications are as follows:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>HSt</strong> – HSt has been classified into:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Overhydrated HSt (OHS)</p><p class="bulletIndent2"><span class="glyph">•</span>Dehydrated HSt (DHS; synonymous with stomatocytic HX)</p><p class="bulletIndent2"><span class="glyph">•</span>Cryohydrocytosis (CHC)</p><p class="bulletIndent2"><span class="glyph">•</span>Familial pseudohyperkalemia (FP)</p><p></p><p class="bulletIndent1">Additional forms of HSt with syndromic features include stomatin-deficient cryohydrocytosis with intellectual disability, seizures, and hepatosplenomegaly; phytosterolemia non-leaky stomatocytosis with macrothrombocytopenia; and dehydrated HSt with perinatal edema and/or pseudohyperkalemia [<a href="#rid1">1</a>]. (See <a class="local">'Genetics'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>HX</strong> – HX has been classified into [<a href="#rid2">2</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Classic HX</p><p class="bulletIndent2"><span class="glyph">•</span>Stomatocytic HX (synonymous with dehydrated HSt)</p><p class="bulletIndent2"><span class="glyph">•</span>HX with hyperphosphatidylcholine hemolytic anemia</p><p></p><p>Genotype-phenotype correlations are increasingly reported, and the classification may benefit from incorporation of this information. (See <a class="local">'Genetics'</a> below.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>SAO</strong> – Southeast Asian ovalocytosis (SAO) is a benign condition not associated with anemia and characterized by increased rigidity of the RBC membrane, with stomatocytes on the peripheral smear. SAO is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/142822.html" rel="external">"Southeast Asian ovalocytosis (SAO)"</a>.)</p><p></p><p class="headingAnchor" id="H3449331804"><span class="h1">GENETICS</span><span class="headingEndMark"> — </span>Classic HSt and HX are autosomal dominant [<a href="#rid1">1,3,4</a>]. De novo germline pathogenic variants are not uncommon; some children will have a negative family history [<a href="#rid5">5</a>].</p><p>The genotypes remain incompletely characterized. Some of the best understood gene variants affect red blood cell (RBC) membrane transporters such as PIEZO1, Gardos channel (<em>KCNN4 </em>gene), Rh-associated glycoprotein (RhAG, CD241), and SLC4A1 (band 3) [<a href="#rid1">1</a>]. In a series of 123 patients with HSt (49 independent pedigrees), nearly one-half of the families had pathogenic variants in <em>PIEZO1</em> [<a href="#rid6">6</a>]. Some genotype-phenotype correlates have been observed, such as compensated hemolysis with <em>PIEZO1 </em>variants and more severe anemia and iron overload with <em>KCNN4</em> variants [<a href="#rid7">7</a>]. (See <a class="local">'PIEZO1'</a> below and <a class="local">'KCNN4 (Gardos channel gene)'</a> below and <a class="local">'RHAG'</a> below and <a class="local">'SCL4A1 (band 3 gene)'</a> below and <a class="local">'ABCB6'</a> below.)</p><p>Additional rare syndromic forms of HSt include [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Pathogenic variants in the glucose transporter <em>SLC2A1</em> can produce hemolytic anemia with stomatocytosis and cold-induced cation leak from the RBCs, as well as hepatosplenomegaly, cataracts, seizures, intellectual disability, and movement disorders [<a href="#rid8">8,9</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pathogenic variants in <em>ABCG5</em> and <em>ABCG8</em>, which encode two ATP-cassette transporters that mediate intestinal transport of dietary sterols, cause dyslipidemia, macrothrombocytopenia, and hemolysis with stomatocytosis [<a href="#rid10">10-12</a>]. The stomatocytosis is most likely due to altered incorporation of sterols in the RBC membrane.</p><p></p><p class="headingAnchor" id="H637383295"><span class="h2"><i>PIEZO1</i></span><span class="headingEndMark"> — </span>Some cases of HSt and classic HX are caused by pathogenic variants in the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F611184&amp;token=87jLzclRwWxNoI%2BQq5Gg7xO3zFQ1DjiQyUyYexwTK9NBRk%2FPVoNAr13vvaSgTDcM&amp;TOPIC_ID=7068" target="_blank"><i>PIEZO1</i></a> gene (also called <em>FAM38A)</em>, which encodes pore-forming subunits of the PIEZO1 channel. </p><p>The word "piezo" comes from the Greek word "piesi," meaning pressure. PIEZO1 is a mechanosensitive channel capable of generating electrical current in response to mechanical tension [<a href="#rid13">13,14</a>]. The function of the channel in normal RBCs is unclear; it may play a role during RBC deformation in small vascular beds.</p><p>Several multigenerational kindreds of HX families with <em>PIEZO1</em> variants have been reported [<a href="#rid13">13,15-21</a>]. These variants cause increased channel activity due to delayed channel inactivation and increased cation transport [<a href="#rid13">13,18,19</a>]. Identification of several novel <em>PIEZO1</em> variants has produced a more complicated picture [<a href="#rid19">19</a>]; these new alleles may exhibit altered response to osmotic stress and impaired membrane trafficking, with some possibly resulting in increased RBC dehydration; they are not necessarily associated with delayed channel inactivation [<a href="#rid19">19,22</a>].</p><p>Many cases of HSt due to<em> PIEZO1</em> variants are characterized by compensated hemolysis, perinatal edema (in approximately one-fifth of affected kindreds), and higher risk of thromboembolic complications post-splenectomy, especially portal thrombosis. In a study that evaluated clinical findings in 29 individuals with a pathogenic variant in <em>PIEZO1</em>, those with a variant affecting the pore domain of the ion channel had a more severe clinical phenotype; however, it was not possible to make extensive genotype-phenotype correlations [<a href="#rid6">6</a>].</p><p>Piezo1 is also expressed in liver and bone marrow during development, suggesting a correlation between pathogenic variants in <em>PIEZO1</em> and the syndromic association of HX, perinatal edema, and pseudohyperkalemia [<a href="#rid17">17</a>]. <em>PIEZO1</em>-activating mutations lead to delayed erythroblast and reticulocyte maturation, possibly by mediating increased calcium entry into erythroblasts [<a href="#rid23">23,24</a>].</p><p>Certain variants in <em>PIEZO1</em> may act as disease modifiers in other hematologic conditions [<a href="#rid25">25,26</a>]. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>Acute hemolysis and profound RBC dehydration have been described in an individual with hemoglobin C trait and a <em>PIEZO1</em> variant [<a href="#rid27">27</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a cohort of 20 beta thalassemia carriers, some individuals had anemia of varying degrees, splenomegaly, alterations in hemolysis indices, and liver hemosiderosis [<a href="#rid28">28</a>]. These individuals, referred to as symptomatic beta thalassemia carriers, were highly likely to have hereditary anemia variants; notably, approximately 93 percent of the symptomatic beta thalassemia carriers had pathogenic variants in the <em>PIEZO1</em> gene.</p><p></p><p>It is also important to evaluate the possible co-inheritance of causative variants in genes related to hereditary stomatocytosis with those causing other RBC disorders. In a case series of 155 consecutive patients with various RBC disorders, 15 percent had multi-locus inheritance (more than one disease variant in each patient) [<a href="#rid26">26</a>]. This mainly involved variants in the <em>PIEZO1</em> and <em>SPTA1</em> genes causing hereditary spherocytosis. </p><p>Additionally, from the genetic perspective, <em>PIEZO1</em> is a large and highly polymorphic gene that exhibits reduced genetic constraints. Consequently, in most cases, the American College of Medical Genetics and Genomics (ACMG) classification fails in assessing the pathogenicity of genetic variants within this gene. Therefore, accurate variant interpretation often necessitates specific knowledge about the patient, gene variant, or specific disease, making it crucial to conduct genetic testing for dehydrated HSt in specialized laboratories. (See  <a class="medical medical_review" href="/z/d/html/2898.html" rel="external">"Genetics: Glossary of terms", section on 'Variant'</a>.)</p><p>Certain variants in <em>PIEZO1</em> appear to be protective against severe malaria, and a 2018 study determined that as much as one-third of the population in certain African countries carry a gain-of-function mutation (E756del) in <em>PIEZO1 </em>that does not cause clinical disease<em> </em>[<a href="#rid29">29</a>]<em>. </em>This allele is also present in approximately 14 percent of African Americans. In another study in individuals with sickle cell disease (SCD), this same allele has been associated with increased red blood cell density [<a href="#rid30">30</a>]. (See  <a class="medical medical_review" href="/z/d/html/7099.html" rel="external">"Protection against malaria by variants in red blood cell (RBC) genes"</a>.)</p><p>The Er red blood group antigens are produced by amino acid substitutions in the extracellular domain of Piezo1 [<a href="#rid31">31</a>]. (See  <a class="medical medical_review" href="/z/d/html/7924.html" rel="external">"Red blood cell antigens and antibodies", section on 'Er blood group system'</a>.)</p><p class="headingAnchor" id="H1098445124"><span class="h2"><i>KCNN4 </i>(Gardos channel gene)</span><span class="headingEndMark"> — </span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F602754&amp;token=87jLzclRwWxNoI%2BQq5Gg75Rxobr%2B0p0HBU7BOqUBoIzcesQq%2BYUkRC8snAz1cThc&amp;TOPIC_ID=7068" target="_blank"><i>KCNN4</i></a> encodes the Gardos channel, the "calcium-activated potassium channel of red blood cells" [<a href="#rid32">32-35</a>]. Each RBC contains approximately 120±36 Gardos channels [<a href="#rid36">36</a>]. No other type of RBC potassium channel has been demonstrated in human RBCs. </p><p>The Gardos channel is activated by micromolar concentrations of calcium (k<sub>50</sub> = 0.3 to 2 micromol/L) and inhibited by charybdotoxin, <a class="drug drug_general" data-topicid="9287" href="/z/d/drug information/9287.html" rel="external">clotrimazole</a>, other imidazole antimycotics, and senicapoc [<a href="#rid37">37-39</a>].</p><p>Some cases of dehydrated HSt (also called stomatocytic HX) are caused by pathogenic variants in<em> KCNN4</em>; these variants are generally associated with more severe anemia and hemolysis than HSt due to variants in <em>PIEZO1</em> and more pronounced iron overload (estimated from serum ferritin values), with variable RBC dehydration. </p><p>Several kindreds with pathogenic variants in <em>KCNN4</em> have been reported, including R352H (in the calmodulin-binding domain) and V282M/E (at the cytoplasmic face of the TM6 portion) [<a href="#rid21">21,40-42</a>]. The RBCs from affected patients have increased channel sensitivity to intracellular calcium that causes reduced cellular potassium and in turn leads to cellular dehydration and formation of xerocytes [<a href="#rid40">40</a>]. With more kindreds being described, more nuanced RBC phenotypes have emerged that suggest the presence of disease modifiers and/or secondary alterations of membrane function due to the profound dehydration and shrinkage of the RBCs [<a href="#rid43">43,44</a>]. </p><p>Activation of the Gardos channel is also thought to contribute to RBC dehydration in sickle cell disease (SCD). Senicapoc, a high-affinity inhibitor of the Gardos channel, was evaluated in patients with SCD, but a randomized trial failed to show measurable clinical benefits compared with placebo [<a href="#rid45">45</a>]. (See  <a class="medical medical_review" href="/z/d/html/110324.html" rel="external">"Investigational therapies for sickle cell disease", section on 'Increasing RBC hydration (senicapoc, memantine)'</a>.)</p><p>The identification of several new variants that cause a constitutively active Gardos channel in individuals with HX and the role played by the Gardos channel in dehydration has led to renewed interest in senicapoc as a candidate for the treatment of HX [<a href="#rid46">46,47</a>].</p><p class="headingAnchor" id="H2782988757"><span class="h2"><i>RHAG</i></span><span class="headingEndMark"> — </span>Overhydrated HSt is caused by pathogenic variants in <em>RHAG</em>, which encodes the Rh antigen-associated glycoprotein (RhAG, CD241) [<a href="#rid48">48,49</a>]. The associated Rh blood group antigen was originally identified using cells from Rhesus monkeys. Some citations retain this term, but the correct name is Rh. (See  <a class="medical medical_review" href="/z/d/html/7924.html" rel="external">"Red blood cell antigens and antibodies", section on 'Rh blood group system'</a>.)</p><p>RhAg is a NH<sub>3</sub>/NH<sub>4</sub><sup>+</sup> transporter; it has also been reported to control RBC gas exchange [<a href="#rid4">4</a>]. RhAG is a component of a macrocomplex with band 3. (See  <a class="medical medical_review" href="/z/d/html/7091.html" rel="external">"Red blood cell membrane: Structure and dynamics", section on 'Band 3'</a>.)</p><p>Heterozygosity for a missense mutation (F65S) in <em>RHAG</em> has been reported in the majority of patients with overhydrated HSt. This variant impairs the function of the channel and increases cation leak; the latter is thought to be an effect on other cellular permeability pathways [<a href="#rid50">50</a>].</p><p class="headingAnchor" id="H482737767"><span class="h2"><i>SCL4A1</i> (band 3 gene)</span><span class="headingEndMark"> — </span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F109270&amp;token=87jLzclRwWxNoI%2BQq5Gg78C3PK3RWUDdckbsN0j1aQB1EENO9Tk9VTX7%2BosXPc4P&amp;TOPIC_ID=7068" target="_blank"><i>SLC4A1</i></a> (for solute carrier) encodes band 3; the gene is also called <em>BND3</em> or <em>AE1</em> (for anion exchanger). Each RBC contains approximately 1.2 million copies of band 3 per cell.</p><p>HSt (typically, the cryohydrocytic form) can be caused by pathogenic variants in <em>SLC4A1</em>. One individual with HSt in association with dyserythropoiesis also had an <em>SLC4A1</em> variant [<a href="#rid51">51</a>]. </p><p>A specific genetic variant in <em>SLC4A1 </em>gene that deletes nine amino acids is responsible for Southeast Asian ovalocytosis (SAO); this condition is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/142822.html" rel="external">"Southeast Asian ovalocytosis (SAO)"</a>.)</p><p>Band 3 has two main functions:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anion exchange</strong> – The protein is an anion exchanger that passively transports bicarbonate ions out of the RBC in exchange for chloride (Cl<sup>-</sup>) ions via the C-terminal membrane-spanning domain. Its physiological function is to facilitate removal or carbon dioxide generated from cellular respiration in the tissues in the form of bicarbonate that can be transported to the lungs [<a href="#rid4">4</a>]. This is related to its ability to bind deoxyhemoglobin, but not oxyhemoglobin, with high affinity [<a href="#rid52">52</a>]. This interaction also mediates a switch in glucose metabolism between the pentose phosphate and the glycolytic pathways, as well as ATP release from the RBC [<a href="#rid53">53</a>]. The bicarbonate ions are used to remove carbon dioxide produced from tissue respiration. </p><p></p><p class="bulletIndent1">All of the SLC4A1 variants that cause HSt appear to interfere with anion transport [<a href="#rid51">51,54-56</a>]. HSt-associated variants are believed to turn the anion exchanger into an unregulated cation channel.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>RBC membrane-cytoskeleton structure</strong> – The protein links ankyrin to the RBC membrane via the N-terminal cytoplasmic domain, which binds the protein complex containing ankyrin, band 4.1, and band 4.2, as well as hemoglobin and glycolytic enzymes.<em> </em>(See  <a class="medical medical_review" href="/z/d/html/7091.html" rel="external">"Red blood cell membrane: Structure and dynamics", section on 'Band 3'</a>.)</p><p></p><p class="bulletIndent1"><em>SLC4A1 </em>variants that interfere with the cytoskeletal functions can cause hereditary spherocytosis (HS) and Southeast Asian ovalocytosis (SAO) [<a href="#rid57">57</a>]. (See  <a class="medical medical_review" href="/z/d/html/7079.html" rel="external">"Hereditary spherocytosis", section on 'Band 3 deficiency due to SLC4A1 variants'</a> and  <a class="medical medical_review" href="/z/d/html/142822.html" rel="external">"Southeast Asian ovalocytosis (SAO)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mitosis </strong>– Band 3 also regulates mitosis in erythropoietic cells and may be involved in dyserythropoietic disorders [<a href="#rid58">58</a>].</p><p></p><p>Absence of band 3 was thought to be incompatible with life due to severe hemolytic anemia [<a href="#rid59">59</a>]. However, band 3 variants have been described in which individuals homozygous for the variant have survived [<a href="#rid60">60</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Band 3 Coimbra (Val488Met)</strong> – Homozygosity causes complete absence of band 3 in RBCs. A newborn with this variant had severe hemolysis, hydrops, distal renal tubular acidosis (RTA), and nephrocalcinosis and required chronic blood transfusion and daily bicarbonate [<a href="#rid61">61,62</a>]. Splenectomy resulted in transfusion independence for nine years, with regular transfusions plus iron chelation restarted at age 12. At age 19, the distal RTA was well controlled with normal kidney function [<a href="#rid63">63</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Band 3 Neapolis</strong> – This variant contains a T-to-C substitution at the +2 position in the donor splice site of intron 2, resulting in an 88 percent reduction of band 3 in RBCs and producing severe, transfusion-dependent hemolytic anemia that improved markedly after splenectomy [<a href="#rid64">64</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Band 3 null</strong><strong><sup>VIENNA</sup></strong><strong> (S477X)</strong> – This variant contains a nonsense mutation that abolishes band 3 expression, associated with transfusion-dependent hemolysis, dyserythropoiesis, and complete distal RTA [<a href="#rid63">63</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Band 3 SAO variant</strong> – This variant deletes nine amino acid residues. It was originally thought to be incompatible with life, but a few individuals have been described with homozygosity for the variant. (See  <a class="medical medical_review" href="/z/d/html/142822.html" rel="external">"Southeast Asian ovalocytosis (SAO)", section on 'Specific SLC4A1 deletion'</a>.)</p><p></p><p class="headingAnchor" id="H3679441314"><span class="h2"><i>ABCB6</i></span><span class="headingEndMark"> — </span>HSt and pseudohyperkalemia has been seen with pathogenic variants in <em>ABCB6</em>, which encodes a porphyrin transporter that serves as the basis for the Langereis (Lan) blood group system [<a href="#rid65">65,66</a>]. (See  <a class="medical medical_review" href="/z/d/html/2377.html" rel="external">"Causes and evaluation of hyperkalemia in adults", section on 'Pseudohyperkalemia'</a>.)</p><p>A 2016 survey of 327 blood donations found evidence of an <em>ABCB6</em> variant in one; after four weeks of storage, the RBCs showed massive loss of K<sup>+</sup>, and the authors suggested that neonates receiving large-volume transfusions of whole blood from a donor with this type of variant could develop hyperkalemia [<a href="#rid67">67</a>].</p><p class="headingAnchor" id="H1905391482"><span class="h1">PATHOPHYSIOLOGY</span></p><p class="headingAnchor" id="H777449114"><span class="h2">Control of RBC solute and water content</span><span class="headingEndMark"> — </span>The red blood cell (RBC) volume is controlled by changes in cations, anions, and cell water, which are continuously regulated by the activity and interactions of several ion transport systems, as summarized in the figure  (<a class="graphic graphic_figure graphicRef62852" href="/z/d/graphic/62852.html" rel="external">figure 1</a>) [<a href="#rid68">68,69</a>]. This includes two energy-drive systems (ATPases) and several passive (gradient-driven) transport systems.</p><p>The importance of these systems is indicated by the various diseases occurring when red cell ion transport is impaired  (<a class="graphic graphic_table graphicRef80358" href="/z/d/graphic/80358.html" rel="external">table 1</a>).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cation transport</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Na-K-ATPase</strong> <strong>pump</strong> – The sodium-potassium (Na-K)-ATPase pump is an energy-driven pump that maintains an intracellular milieu low in Na and high in K. It extrudes three Na ions in exchange for two K<sup>+</sup> ions. It has three subunits (alpha-1 catalytic subunit that transports ions, beta-1 subunit that binds membrane and cytoskeletal components, and gamma-1 proteolipid subunit) [<a href="#rid70">70,71</a>]. </p><p></p><p class="bulletIndent2">Each RBC contains approximately 228 to 470 Na-K-ATPase units [<a href="#rid72">72</a>]. </p><p></p><p class="bulletIndent2">The outward K<sup>+</sup> gradient and the inward Na gradient is used by several passive transport systems that are sensitive to changes in pH, volume, or membrane integrity (the pump-leak model) [<a href="#rid73">73</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Ca-ATPase pump</strong> – The calcium (Ca)-ATPase pump is a powerful energy-driven pump that maintains low free cytosolic calcium levels (&lt;0.1 µmol/L) [<a href="#rid74">74</a>]. The pump extrudes one Ca ion in exchange for one hydrogen ion at the expense of one ATP molecule.</p><p></p><p class="bulletIndent2">Activity of the Ca-ATPase pump varies between RBCs in the same individual, with subpopulations of RBCs in which activity can vary six- to ninefold [<a href="#rid75">75</a>]. Normal RBC aging is associated with decreased Ca-ATPase activity [<a href="#rid76">76</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Na-Mg exchanger (</strong><strong><em>SLC41A1</em></strong><strong> gene)</strong> – RBCs have a high total magnesium (Mg) but a less free Mg. Mg regulates several cellular functions; its export from RBCs is regulated by a gradient-driven Na-Mg exchanger (or antiporter, encoded by the <em>SCL41A1</em> gene) that exports Mg in exchange for Na [<a href="#rid77">77,78</a>]. </p><p></p><p class="bulletIndent2">Mechanisms that control magnesium entry into RBCs are not well understood.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Na-H exchanger (</strong><strong><em>SLC9A1</em></strong><strong> gene)</strong> – The Na-hydrogen (H) exchanger (or antiporter, encoded by the <em>SLC9A1</em> [also called <em>NHE1</em>] gene) transports Na into RBCs in exchange for H, accounting for a small fraction of the passive Na influx [<a href="#rid79">79</a>]. The exchanger is regulated by protein 4.1R; deletion in a mouse model causes spherocytosis [<a href="#rid80">80,81</a>]. (See  <a class="medical medical_review" href="/z/d/html/7079.html" rel="external">"Hereditary spherocytosis", section on 'Pathophysiology'</a>.)</p><p></p><p class="bulletIndent2">In non-RBC cells, Na-H exchange regulates pH and mediates volume increase following hypertonic shrinkage.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>TRPC6 channels</strong> – Transient receptor potential channels of canonical type 6 (TRPC6) channels are responsible for the leak of Ca into RBCs [<a href="#rid82">82</a>]. They may become active in the terminal phase of the erythrocyte lifespan and help to initiate eryptosis (apoptosis-like death of erythrocytes) [<a href="#rid83">83</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anion transport </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Band 3/AE1 (</strong><strong><em>SLC4A1</em></strong><strong> gene) </strong>– Band 3 (anion exchanger 1 [AE1]) exchanges chloride and bicarbonate ions. (See <a class="local">'SCL4A1 (band 3 gene)'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Na</strong><strong><sup>+</sup></strong><strong>-K</strong><strong><sup>+</sup></strong><strong>-Cl</strong><strong><sup>-</sup></strong><strong> cotransporter (</strong><strong><em>SLC12A</em></strong><strong> gene)</strong> – The<strong> </strong>Na-K-Chloride (Cl) cotransporter is present on RBCs as well as numerous other cell types [<a href="#rid84">84</a>]. The major erythroid form extrudes one Na and one K<sup>+ </sup>with two Cl<sup>-</sup> [<a href="#rid85">85</a>]. It plays a minor role in regulating RBC volume.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>K</strong><strong><sup>+</sup></strong><strong>-Cl</strong><strong><sup>-</sup></strong><strong> cotransporter (</strong><strong><em>SCL12A4</em></strong><strong> gene)</strong> – The K<sup>+</sup>-Cl<sup>-</sup> cotransporter belongs to the family of chloride-cation transporters (CCC) that contains at least four major isoforms (KCC1-4) expressed in different cell types (RBCs express KCC1, 3, and 4) [<a href="#rid86">86-89</a>]. It extrudes K<sup>+</sup> and Cl<sup>-</sup>. It is activated by cell swelling and hydrostatic pressure, as well as by urea, oxidation, and positively charged hemoglobin variants [<a href="#rid90">90-101</a>]. It is inhibited by intracellular divalent cations including Mg and zinc [<a href="#rid102">102</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Water diffusion and transport</strong> – Water movement passively follows that of intracellular cations (Na<sup>+</sup>, K<sup>+</sup>) and anions (Cl<sup>-</sup>) or is induced by changes in tonicity of the environment surrounding the RBC. Water can be transported more rapidly by aquaporin-1 (AQP-1, previously called CHIP28) [<a href="#rid103">103,104</a>]. </p><p></p><p class="bulletIndent1">The Colton blood group antigen polymorphism is a single amino acid substitution in an extracellular domain of AQP-1 [<a href="#rid105">105</a>]. Colton-null individuals lack AQP-1 and have a modest reduction in urinary concentrating ability [<a href="#rid106">106,107</a>]. (See  <a class="medical medical_review" href="/z/d/html/7924.html" rel="external">"Red blood cell antigens and antibodies", section on 'Colton blood group system'</a>.)</p><p></p><p class="bulletIndent1">Normal RBC aging is accompanied by progressively increased cell density due to loss of K<sup>+</sup> and water, until the terminal phase of the RBC lifespan, when dense RBCs gain Na, swell, and are removed from the circulation [<a href="#rid108">108,109</a>].</p><p></p><p class="headingAnchor" id="H1905391503"><span class="h2">Stomatocyte formation</span><span class="headingEndMark"> — </span>When the normal biconcave disc becomes a uniconcave cup  (<a class="graphic graphic_picture graphicRef68313" href="/z/d/graphic/68313.html" rel="external">picture 4</a> and <a class="graphic graphic_picture graphicRef130751" href="/z/d/graphic/130751.html" rel="external">picture 2</a>), a RBC will appear as a stomatocyte on the peripheral blood smear  (<a class="graphic graphic_picture graphicRef75535" href="/z/d/graphic/75535.html" rel="external">picture 1</a>). </p><p>In vitro studies have led to the proposal that relative expansion of the inner leaflet of the bilayer relative to the outer leaflet may be responsible [<a href="#rid110">110</a>]. This conclusion is based on studies in which RBC shapes can be modified by exposure to amphiphilic agents (compounds that can simultaneously interact with liquids [such as cytoplasm] and lipids [in membranes]). These compounds are thought to intercalate passively into the relatively negatively charged inner half of the membrane phospholipid bilayer, causing an inner bulging (the beginning of the cup)  (<a class="graphic graphic_figure graphicRef55556" href="/z/d/graphic/55556.html" rel="external">figure 2</a>) [<a href="#rid110">110,111</a>]. Endocytic vacuoles then form at the advancing mouth causing the loss of surface area that completes the transformation to a stomatocyte. </p><p>There are several mechanisms by which this change can occur:</p><p class="bulletIndent1"><span class="glyph">●</span>In HSt, the mechanism often involves changes in cell volume caused by reduced intracellular ion content. (See <a class="local">'Control of RBC solute and water content'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In most acquired stomatocytosis and rare inherited conditions that affect lipid metabolism, the mechanism often involves a decrease in RBC membrane surface area or qualitative changes in the composition of the membrane lipid bilayer.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In some healthy individuals, stomatocytes occasionally can be found due to a drying artifact; hence, it is important to evaluate several different areas of the peripheral smear before determining that a patient has circulating stomatocytes.</p><p></p><p>In contrast with expansion of the inner leaflet of the membrane, which is postulated to produce stomatocytes, expansion of the outer leaflet leads to echinocytes (burr cells). However, other theories postulate that alterations in structure and/or function of band 3 or other cytoskeletal protein may result in stomatocytic or echinocytic changes. (See  <a class="medical medical_review" href="/z/d/html/7088.html" rel="external">"Burr cells, acanthocytes, and target cells: Disorders of red blood cell membrane", section on 'Causes of burr cells'</a>.)</p><p>Alterations in ion content can also cause stomatocytosis. In disorders characterized by overhydration of the RBCs, stomatocytosis may represent a step in the transformation of a discocyte into an overhydrated spherocyte, which is followed by RBC fragmentation. In RBC dehydration disorders, stomatocytes may be a step in the generation of dehydrated spherocytes and/or echinocytes.</p><p class="headingAnchor" id="H2866626948"><span class="h2">Xerocyte formation</span><span class="headingEndMark"> — </span>Xerocytes are dense, hyperchromic RBCs. They form when loss of cell solutes induces osmotic water loss. (See <a class="local">'Control of RBC solute and water content'</a> above.)</p><p>In xerocytosis, potassium (K<sup>+</sup>), the main intracellular cation, is lost. This may be associated with a slight increase in intracellular sodium (Na<sup>+</sup>), but the net cation content of the RBC is significantly lower than in control RBCs. </p><p>When the leakage of K<sup>+</sup> out of the cell exceeds the rate at which it is pumped back in, low intracellular K<sup>+</sup> and dehydration ensue [<a href="#rid5">5</a>]. If the permeability of the membrane to Na<sup>+</sup> is abnormally high and the Na<sup>+</sup>-K<sup>+</sup>-ATPase is unable to fully compensate, the cells gain Na<sup>+</sup> with overhydration [<a href="#rid5">5,112</a>]. (See <a class="local">'Control of RBC solute and water content'</a> above.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dehydration</strong> – Dehydration occurs with loss of intracellular cations (K<sup>+</sup>), which leads to osmotic water loss. Dehydrated stomatocytes have markedly decreased intracellular K<sup>+</sup> with normal or increased intracellular Na<sup>+</sup>.</p><p></p><p class="bulletIndent1">Dehydrated HSt (also called stomatocytic HX) has been linked to variants in the genes encoding the Piezo1 and Gardos channels. (See <a class="local">'Genetics'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overhydration</strong> – Overhydrated HSt is less common than dehydrated HSt. Overhydration occurs when cellular permeability to Na<sup>+</sup> increases (cation leak into the cell), leading to a marked increase in intracellular Na<sup>+</sup> that cannot be compensated for by the Na<sup>+</sup>-K<sup>+</sup>-ATPase pump [<a href="#rid113">113</a>]. The increased intracellular cation content causes an osmotic increase in cell water, leading to overhydrated HSt. </p><p></p><p class="bulletIndent1">Overhydrated HSt may be caused by pathogenic variants in the <em>RHAG</em> gene, which controls cation flux. (See <a class="local">'Genetics'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cryohydrocytosis</strong> – Cryohydrocytosis is a rare form of overhydrated HSt associated with hemolysis of RBCs in vitro when the cells are refrigerated [<a href="#rid114">114</a>]. Cryohydrocytes are RBCs that have a mild cation leak at body temperature and a marked increase in cation permeability at refrigerator temperature [<a href="#rid113">113</a>]. Thus, they become overhydrated when refrigerated; they may also form stomatocytes or microspherocytes in vitro and/or leak sufficient K<sup>+</sup> into the plasma in the collection tube to cause pseudohyperkalemia [<a href="#rid5">5,114,115</a>]. In some cases, pathogenic variants in <em>SLC4A1</em>, which encodes band 3, have been reported [<a href="#rid116">116-119</a>]. Two cases of stomatin deficiency associated with variants in<em> SLC2A1</em> have been reported [<a href="#rid9">9</a>]. HSt associated with pseudohyperkalemia has been designated familial pseudohyperkalemia. (See <a class="local">'Clinical manifestations'</a> below and  <a class="medical medical_review" href="/z/d/html/2377.html" rel="external">"Causes and evaluation of hyperkalemia in adults", section on 'Pseudohyperkalemia'</a>.)</p><p></p><p>Dehydration also usually produces target cells, and pronounced dehydration produces xerocytes, which is reflected by a substantially increased mean corpuscular hemoglobin concentration (MCHC)  (<a class="graphic graphic_picture graphicRef62761" href="/z/d/graphic/62761.html" rel="external">picture 3</a>) [<a href="#rid120">120</a>]. Xerocytes have <strong>decreased</strong> osmotic fragility due to the small baseline cell size. Xerocytes also exhibit a characteristic increase in cell rigidity and reduction in deformability, changes that are thought to promote hemolysis. (See <a class="local">'Effects on the RBC (hemolysis, metabolic abnormalities, membrane changes)'</a> below.)</p><p class="headingAnchor" id="H1905392092"><span class="h2">Effects on the RBC (hemolysis, metabolic abnormalities, membrane changes)</span><span class="headingEndMark"> — </span>The precise mechanisms leading to hemolysis are unknown. A reduction in deformability leading to increased sensitivity to mechanical or shear stress is believed to be a unifying mechanism of hemolysis for all types of stomatocytosis. Hemolysis is mostly extravascular, although there may be an intravascular component in severe cases. Intravascular hemolysis was reported in a patient with HX during intensive exercise [<a href="#rid121">121</a>].</p><p>In some patients, anemia is absent and hemolysis can be observed only in particular conditions associated with increased mechanical stress to the RBCs [<a href="#rid15">15,121</a>]. (See <a class="local">'Compensated hemolysis and hemolytic anemia'</a> below.)</p><p>Reduced deformability has been quantified in the research setting using techniques such as osmotic gradient ektacytometry, but the results do not necessarily predict the behavior of the RBCs in vivo. Less deformable RBCs are believed to be predisposed to trapping in the microvasculature of the spleen and other organs of the reticuloendothelial system, which can lead to increased phagocytosis and varying degrees of extravascular hemolysis. </p><p>In addition to hemolysis, overhydrated HSt RBCs have a distinct set of metabolic abnormalities, alterations in adherence to the endothelium, and a deficiency in the stomatin protein.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Metabolic</strong> – Metabolic abnormalities in RBCs of patients with overhydrated HSt include increased adenosine diphosphate (ADP), reduced 2,3-bisphosphoglycerate (2,3-BPG, previously called 2,3-DPG), and enhanced oxygen affinity [<a href="#rid122">122,123</a>]. Many of these findings are consistent with increased ATP production, which is needed to support the increased activity of the Na<sup>+</sup>-K<sup>+</sup>-ATPase required to compensate for the increased Na<sup>+</sup> permeability. Other changes include increases in oxidized glutathione efflux, accumulation of glutamine and tryptophan, abnormal phosphatidylserine externalization, and decreases in creatine transport and concentration of ergothioneine, but the mechanism is not clear [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Membrane</strong> – RBC membrane abnormalities have been reported in various forms of HSt and HX. It is unclear whether these have any causal roles in hemolysis or other clinical manifestations. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>RBCs from some patients with HSt have increased adherence to endothelium [<a href="#rid124">124</a>]. The abnormal stickiness may mediate thromboembolic complications seen in these patients, particularly after splenectomy. (See <a class="local">'Other findings'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>RBCs from some patients with overhydrated HSt were deficient in the membrane protein stomatin (also known as band 7.2b) [<a href="#rid3">3,125-127</a>]. The function of stomatin is uncertain, but studies in mice suggest its deficiency alone does not cause stomatocytosis or hemolysis [<a href="#rid13">13,15,16</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>RBCs from some patients with HX have a relative increase of membrane phosphatidylcholine, leading to the designation of "HX with hyperphosphatidylcholine hemolytic anemia" [<a href="#rid2">2,116,128-130</a>]. This abnormality is accompanied by an increase in membrane permeability to K<sup>+</sup> and cellular dehydration.</p><p></p><p class="headingAnchor" id="H1905393206"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>HSt and HX are rare. The incidences were estimated from a 2015 United Kingdom series [<a href="#rid5">5</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Dehydrated HSt (stomatocytic HX) – 100 per 1 million births (1 in 10,000)</p><p class="bulletIndent1"><span class="glyph">●</span>Overhydrated HSt – 1 per 1 million births</p><p class="bulletIndent1"><span class="glyph">●</span>Cryohydrocytosis (a form of HSt) – Extremely rare</p><p class="bulletIndent1"><span class="glyph">●</span>Familial pseudohyperkalemia (a form of HSt) – Extremely rare</p><p></p><p>By comparison, the incidence of hereditary spherocytosis is &gt;200 to 300 per 1 million births. (See  <a class="medical medical_review" href="/z/d/html/7079.html" rel="external">"Hereditary spherocytosis", section on 'Disease prevalence'</a>.)</p><p>A greater incidence of mild HX has been proposed based on a laboratory analysis of routine complete blood counts (CBCs) that showed a higher-than-expected proportion of individuals with possible HX based on the finding of an increased mean corpuscular hemoglobin concentration (MCHC) [<a href="#rid131">131</a>]. (See <a class="local">'Diagnosis'</a> below.)</p><p class="headingAnchor" id="H1905393240"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H4236869571"><span class="h2">Typical presentations</span><span class="headingEndMark"> — </span>HSt and HX can be asymptomatic or can produce chronic hemolytic anemia of varying severity. The most common presentation is of compensated hemolysis or mild anemia, high reticulocyte count, and elevated mean corpuscular hemoglobin concentration (MCHC) and mean corpuscular hemoglobin (MCH). The mean corpuscular volume (MCV) can show mild macrocytosis due to increased reticulocytes. Chronic fatigue is often present in the absence of significant anemia. </p><p>The age of presentation depends on the specific variant as well as other inherited conditions and environmental factors. </p><p class="bulletIndent1"><span class="glyph">●</span>In neonates, the physical examination is generally unremarkable, although it may show pallor, jaundice, and/or ascites in a severely affected neonate. Prenatal and/or perinatal edema has been reported, which in rare cases has been associated with life-threatening hydrops fetalis. Edema usually disappears spontaneously before birth or a few months thereafter [<a href="#rid132">132-134</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In many cases, diagnosis is made in early adulthood, since many individuals do not have symptoms related to anemia, and symptoms related to other complications (gallstones, iron overload, splenomegaly) occur later. Often the appearance can be attributed solely to iron overload, as exemplified by carriers of the <em>PIEZO1</em> E756del variant (associated with malaria resistance), or in other instances where dehydrated HSt was masquerading as primary hemochromatosis [<a href="#rid6">6,29,135,136</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The increasing use of the complete blood count (CBC) in asymptomatic individuals has resulted in earlier diagnosis in some individuals who otherwise might never have come to medical attention. In many individuals, an elevated reticulocyte count, MCHC, or MCH with normal hemoglobin prompts additional investigations leading to the diagnosis of HSt or HX. Evidence of hemolytic anemia may be present, but there is rarely a history of need for transfusions. Some patients may be misdiagnosed as having hereditary spherocytosis (HS) and are only correctly diagnosed as having HSt after the occurrence of thrombotic complications post-splenectomy. (See <a class="local">'Splenectomy'</a> below.)</p><p></p><p>Two large case series summarize the likelihood of different clinical features:</p><p class="bulletIndent1"><span class="glyph">●</span>In a series of 123 individuals with HSt (49 families), the predominant features were mild macrocytic anemia (mean hemoglobin, 12.5; mean MCV, 99.1), splenomegaly, gallstones, and increased ferritin [<a href="#rid6">6</a>]. The mean age at diagnosis was 21 years for individuals with <em>PIEZO1</em> variants and 47 years for <em>ABCB6</em> variants. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a series of 126 individuals with HX (64 families), the predominant features were hemolysis that persisted following splenectomy, gallstones, splenomegaly, and high serum ferritin (mean ferritin, 764 ng/mL) [<a href="#rid137">137</a>]. Anemia was absent in most (median hemoglobin, 13.1) and none required regular transfusions. The median age at diagnosis of the probands was 32 years (range, birth to 88 years); 11 were diagnosed before the age of 1 year. <em>PIEZO1</em> variants were associated with compensated hemolysis, perinatal edema, and post-splenectomy thrombosis, especially in the portal system.</p><p></p><p class="headingAnchor" id="H2842962023"><span class="h2">Compensated hemolysis and hemolytic anemia</span><span class="headingEndMark"> — </span>HSt and HX are characterized by compensated hemolysis or hemolytic anemia and abnormal red blood cell (RBC) morphologies on the peripheral blood smear. For some, chronic hemolytic anemia may be exacerbated by concomitant viral infections and sometimes transient aplastic crises. </p><p>An exception is familial pseudohyperkalemia, which is an asymptomatic carrier state that is not associated with clinical hemolysis [<a href="#rid5">5</a>].</p><p>As noted above, fatigue may be out of proportion to the degree of anemia (see <a class="local">'Typical presentations'</a> above). The severity of fatigue is attributed to the left-shift in the oxyhemoglobin dissociation curve. (See  <a class="medical medical_review" href="/z/d/html/7072.html" rel="external">"Structure and function of normal hemoglobins", section on 'Oxygen affinity'</a>.) </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemolysis</strong> – Typical findings include elevated reticulocyte count, increased lactate dehydrogenase (LDH) and bilirubin, and low haptoglobin. The direct antiglobulin test (DAT; Coombs test) is negative. </p><p></p><p class="bulletIndent1">Some individuals have chronic hemolysis, and others may have no hemolysis at baseline but may develop hemolysis in settings of stress such as infections or exercise. An example of the latter was reported in a competitive freestyle swimmer with HX, who had normal hemoglobin levels at rest but developed intravascular hemolysis and xerocytosis following exercise; he and his two affected sons were subsequently shown to carry the R2488Q <em>PIEZO1</em> mutation [<a href="#rid15">15,121</a>]. Since xerocytes are more sensitive to shear stress, the increase in hemolysis with exercise may have resulted from a shift of blood flow to vessels in exercising muscle, which have smaller diameters and higher shear rates.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anemia</strong> – Individuals with HSt or HX have varying degrees of hemolytic anemia. The severity of anemia depends on the magnitude of hemolysis and the robustness of compensatory reticulocytosis. Some individuals may have severe hemolytic anemia, others may have evidence of compensated hemolysis, with reticulocytosis sufficient to maintain a normal hemoglobin/hematocrit despite ongoing hemolysis, and others may have no evidence of hemolysis [<a href="#rid138">138</a>].</p><p></p><p class="bulletIndent1">In neonates presenting with hemolytic anemia, the severity may be great enough to necessitate neonatal exchange transfusion. Perinatal cases with severe intrauterine ascites or hydrops fetalis have also been described [<a href="#rid118">118,119,132,133,139</a>]. While most of the cases of nonimmune hydrops fetalis do not have a clear genetic basis, an activating <em>PIEZO1</em> mutation is considered diagnostic of a genetic variant [<a href="#rid140">140</a>].</p><p></p><p class="bulletIndent1">In a large case series that included 73 individuals with HSt, the mean hemoglobin was 12.5 g/dL and the mean corpuscular volume (MCV) was 99 fL [<a href="#rid6">6</a>]. In another case series, two-thirds of the patients had compensated hemolysis [<a href="#rid7">7</a>]. </p><p></p><p class="bulletIndent1">In some cases, the severity of anemia may suggest a specific genetic disorder. As examples, milder anemia and compensated hemolysis may indicate a<em> PIEZO1</em> variant, whereas more severe anemia may indicate a <em>KCNN4 </em>variant. If a familial gene variant is not known, this information can be used to ensure that genetic testing includes the gene(s) most likely to be affected. (See <a class="local">'Role of testing/which tests to perform'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>RBC morphology</strong> – The blood smear shows stomatocytes  (<a class="graphic graphic_picture graphicRef75535" href="/z/d/graphic/75535.html" rel="external">picture 1</a>) in HSt and xerocytes  (<a class="graphic graphic_picture graphicRef62761" href="/z/d/graphic/62761.html" rel="external">picture 3</a>) in HX. In some cases, both morphologies may be present, and in others, there may be additional abnormalities such as target cells. </p><p></p><p class="bulletIndent1">The percentage of stomatocytes may be as high as 40 to 60 percent in individuals with HSt [<a href="#rid112">112</a>]. The degree of stomatocytosis does not appear to correlate with the severity of hemolytic anemia [<a href="#rid112">112</a>]. </p><p></p><p class="headingAnchor" id="H2341811964"><span class="h2">Iron overload</span><span class="headingEndMark"> — </span>Iron overload is frequently present. Therapies to address iron overload may be appropriate, especially in the presence of other conditions promoting iron overload such as hereditary hemochromatosis and/or a large number of transfusions [<a href="#rid6">6,15</a>]. (See <a class="local">'Management'</a> below and  <a class="medical medical_review" href="/z/d/html/7146.html" rel="external">"Iron chelators: Choice of agent, dosing, and adverse effects"</a>.)</p><p class="headingAnchor" id="H1905393486"><span class="h2">Other findings</span><span class="headingEndMark"> — </span>HSt or HX can lead to consequences of hemolysis such as splenomegaly, pigmenturia, and/or pigmented gallstones [<a href="#rid20">20</a>]. </p><p>Additional complications such as vaso-occlusion and/or thrombosis appear to be related to interactions between stomatocytes and the vasculature. These are more common following splenectomy, presumably because more stomatocytes remain in the circulation [<a href="#rid65">65,117</a>]. (See <a class="local">'Management'</a> below.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vaso-occlusion</strong> – Some patients with HSt develop acute vaso-occlusive episodes similar to those seen in sickle cell disease (SCD) (see  <a class="medical medical_review" href="/z/d/html/7119.html" rel="external">"Overview of the clinical manifestations of sickle cell disease", section on 'Vaso-occlusive pain'</a>). The symptoms may include dyspnea, chest pain, or abdominal pain and are thought to result from enhanced adherence of stomatocytes to vascular endothelium [<a href="#rid124">124</a>]. This problem appears to be more common after splenectomy, perhaps because more stomatocytes remain in the circulation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Thrombosis</strong> – Some patients with HSt develop thrombosis, which may lead to pulmonary hypertension or other chronic complications. Thrombotic complications are frequently reported following splenectomy [<a href="#rid141">141</a>]. One series of nine patients with HSt described severe thrombotic complications following splenectomy in four (pulmonary hypertension in three and portal hypertension in one) [<a href="#rid65">65</a>].</p><p></p><p>Additional findings related to the genetic defect may occur:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pseudohyperkalemia</strong> – Some individuals with dehydrated HSt/stomatocytic HX have pseudohyperkalemia (an artifactual increase in serum K<sup>+</sup> following storage of the blood sample at low temperature). This is a heterogenous disorder associated with varying degrees of hemolytic anemia or no anemia at all [<a href="#rid8">8,142,143</a>]. The finding of pseudohyperkalemia may be the only abnormality in some individuals with mild cryohydrocytosis. (See  <a class="medical medical_review" href="/z/d/html/2377.html" rel="external">"Causes and evaluation of hyperkalemia in adults", section on 'Pseudohyperkalemia'</a>.)</p><p></p><p class="bulletIndent1">The finding of pseudohyperkalemia (rather than true hyperkalemia) can be verified by measuring K<sup>+</sup> levels in paired samples, one kept at body temperature and the other at refrigerator temperature or on ice; in pseudohyperkalemia, the warm sample will show a normal K<sup>+</sup> level and the cold sample will show hyperkalemia. Once the artifactual nature of the hyperkalemia is established, no further intervention for this finding is needed, although it is useful to note in the medical record that blood should not be refrigerated prior to testing. A search for the underlying genetic cause is of academic interest but not clinically relevant unless it is required for genetic testing.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neurologic problems</strong> – Reports have described cases in which HSt was associated with congenital intellectual disability, seizures, and cataracts; the gene variants responsible are not known [<a href="#rid144">144</a>]. (See <a class="local">'Genetics'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Thrombocytopenia</strong> – A syndromic form of HSt is associated with macrothrombocytopenia and abnormal bleeding [<a href="#rid1">1</a>]. (See <a class="local">'Genetics'</a> above.)</p><p></p><p class="headingAnchor" id="H4162258651"><span class="h1">EVALUATION</span></p><p class="headingAnchor" id="H3533359809"><span class="h2">Diagnostic workflow</span><span class="headingEndMark"> — </span>Typically, the diagnostic workflow for these conditions involves three lines of investigations:</p><p class="bulletIndent1"><span class="glyph">●</span>Initial evaluations that would lead to consideration of the diagnosis, including the complete blood count (CBC), blood smear review, and review of the family history and transmission pattern. (See <a class="local">'When to suspect the diagnosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Biochemical testing and specialized analyses to identify the disorder.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Molecular testing, typically done using a next-generation sequencing (NGS) approach, including targeted NGS gene panels or whole exome sequencing [<a href="#rid145">145</a>].</p><p></p><p class="headingAnchor" id="H2868091836"><span class="h2">When to suspect the diagnosis</span><span class="headingEndMark"> — </span>HSt or HX may be suspected in individuals with any of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Positive family history of HSt or HX, especially in a first-degree relative</p><p class="bulletIndent1"><span class="glyph">●</span>History of unexplained neonatal anemia and hyperbilirubinemia</p><p class="bulletIndent1"><span class="glyph">●</span>Non-immune hemolysis for which the cause remains unknown after routine initial testing</p><p class="bulletIndent1"><span class="glyph">●</span>Otherwise unexplained stomatocytes or xerocytes on the blood smear</p><p class="bulletIndent1"><span class="glyph">●</span>Elevated mean corpuscular hemoglobin concentration (MCHC) and mean corpuscular hemoglobin (MCH) without another explanation </p><p class="bulletIndent1"><span class="glyph">●</span>Elevated ferritin and transferrin saturation (TSAT) without another explanation</p><p></p><p>Findings consistent with non-immune hemolysis include an increased reticulocyte count (unless there is a concomitant cause of anemia that impairs red cell production), increased lactate dehydrogenase (LDH) and bilirubin, and decreased haptoglobin. The direct antiglobulin test (DAT; Coombs test) is negative; one exception is following a recent transfusion that led to generation of an alloantibody. Anemia may be present, but if compensation is adequate, the hemoglobin value may be normal or only mildly decreased. (See  <a class="medical medical_review" href="/z/d/html/5932.html" rel="external">"Overview of hemolytic anemias in children"</a> and  <a class="medical medical_review" href="/z/d/html/7076.html" rel="external">"Diagnosis of hemolytic anemia in adults"</a>.)</p><p>For individuals who do not have hemolytic anemia but for whom the diagnosis is suspected for one of the other reasons listed above, there may be benefits to making the diagnosis that include avoiding other extensive evaluations, avoiding splenectomy for other reasons, monitoring for signs of iron overload, and/or providing genetic counseling. The information may also be helpful if the patient is hospitalized for an acute illness and develops hemolytic anemia due to the stress of the illness.</p><p class="headingAnchor" id="H760807659"><span class="h2">Initial testing</span><span class="headingEndMark"> — </span>Evaluation for HSt and HX includes the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>CBC</strong> – Review the complete blood count (CBC) and peripheral blood smear, which may show stomatocytes  (<a class="graphic graphic_picture graphicRef75535" href="/z/d/graphic/75535.html" rel="external">picture 1</a>) and/or xerocytes  (<a class="graphic graphic_picture graphicRef62761" href="/z/d/graphic/62761.html" rel="external">picture 3</a>), as well as target cells, schistocytes, or eccentrocytes. The stomatocyte shape in three dimensions is illustrated in the electron microscopy images (used for research)  (<a class="graphic graphic_picture graphicRef130751" href="/z/d/graphic/130751.html" rel="external">picture 2</a>). </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The blood smear should be reviewed closely to ensure there are no abnormalities of white blood cells (WBCs) or platelets; WBC and platelet counts are normal in HSt and HX.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The red blood cell (RBC) indices typically show an increased mean corpuscular volume (MCV) of up to 140 femtoliters (fL) and abnormal MCHC (decreased in overhydrated HSt [typically 24 to 28 g/dL], increased in dehydrated HSt [typically 35 to 37 g/dL])  (<a class="graphic graphic_figure graphicRef75542" href="/z/d/graphic/75542.html" rel="external">figure 3</a>) [<a href="#rid5">5</a>]. The impedance method used by Coulter instruments to measure MCHC underestimates the MCHC of dehydrated cells; as a result, diagnosis of HX may be missed unless instruments that directly measure MCHC are used [<a href="#rid115">115</a>]. MCH is frequently elevated as well, possibly due to the concomitant iron overload. (See  <a class="medical medical_review" href="/z/d/html/5927.html" rel="external">"Approach to the child with anemia", section on 'Red blood cell indices'</a> and  <a class="medical medical_review" href="/z/d/html/7133.html" rel="external">"Diagnostic approach to anemia in adults", section on 'RBC indices'</a>.) </p><p></p><p class="bulletIndent1">The algorithm summarizes an approach to the evaluation based on findings from the CBC and blood smear  (<a class="graphic graphic_algorithm graphicRef130750" href="/z/d/graphic/130750.html" rel="external">algorithm 1</a>).</p><p></p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rule out other anemias</strong> – It is appropriate to confirm the initial findings and the lack of an immune mechanism and in some cases to rule out hemoglobinopathy or a microangiopathic process before proceeding to more specialized testing. This typically involves documenting a negative DAT and confirming that other concerning findings such as schistocytes and thrombocytopenia are absent. </p><p></p><p class="bulletIndent1">In some cases, hemoglobin analysis (eg, by high-performance liquid chromatography [HPLC]) may be reasonable. Measurement of plasma potassium<sup> </sup>(K<sup>+</sup>) may be helpful if it shows pseudohyperkalemia, but absence of this finding is not informative [<a href="#rid5">5</a>]. (See <a class="local">'Other findings'</a> above.)</p><p></p><p class="bulletIndent1">Southeast Asian ovalocytosis (SAO) has stomatocytic cells on the blood smear, but other differences help distinguish SAO from HSt and HX. (See <a class="local">'Other causes of stomatocytosis'</a> below and  <a class="medical medical_review" href="/z/d/html/142822.html" rel="external">"Southeast Asian ovalocytosis (SAO)", section on 'Evaluation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Family history</strong> – Family history and transmission patterns should also be reviewed. Classic HSt and HX are autosomal dominant. Some individuals may have a de novo variant and a negative family history. (See <a class="local">'Genetics'</a> above.)</p><p></p><p>Our approach is consistent with a 2015 Guideline that addresses diagnostic testing for individuals with non-immune hereditary RBC membrane disorders [<a href="#rid5">5</a>].</p><p>In individuals for whom this testing is suggestive of HSt or HX, additional testing may include osmotic fragility and/or genetic analysis for possible gene variants associated with HSt and/or HX. (See <a class="local">'Osmotic fragility or ektacytometry'</a> below and <a class="local">'Genetic testing'</a> below.)</p><p class="headingAnchor" id="H1272506336"><span class="h2">Osmotic fragility or ektacytometry</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Osmotic fragility</strong> – Osmotic fragility testing is generally performed after consultation with the hematologist or other expert in evaluation of anemias. </p><p></p><p class="bulletIndent1">Interpretation of the results is as follows:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Decreased osmotic fragility (non-incubated) and decreased RBC K<sup>+</sup> and total cation content is seen in dehydrated HSt.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Increased osmotic fragility (non-incubated) and increased RBC Na<sup>+</sup> and total cation content is seen in overhydrated HSt [<a href="#rid146">146</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Autohemolysis at 4°C (greater at pH 8 than at pH 7.6 to 7.4) is seen in cryohydrocytic HSt [<a href="#rid146">146,147</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Stability to hemolysis upon exposure to high temperature (46 and 49°C for 15 to 60 minutes) and decreased K<sup>+</sup> and total cation content is seen in HX [<a href="#rid114">114</a>].</p><p></p><p class="bulletIndent1">Differences between the results in HSt, HX, and hereditary spherocytosis (HS) are discussed below. (See <a class="local">'Differential diagnosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ektacytometry</strong> – Osmotic gradient ektacytometry is an alternative technique used in Europe that provides a reliable diagnosis of the disease due to its unique pattern in HSt and HX [<a href="#rid1">1,42,137,148</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>HX (dehydrated HSt)</strong> – In HX due to variants in <em>PIEZO1</em>, there is a leftward shift of the minimum in the deformability index (Omin) at low osmolarities, accompanied by a decrease in DI max [<a href="#rid1">1</a>]. For HX due to variants in <em>KCNN4</em>, the curve is normal.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Overhydrated HSt</strong> – There is a rightward shift in the osmolarity curve [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>SAO </strong>– There is a unique pattern in which RBCs are completely non-deformable, resulting in a nearly flat curve across a wide osmotic gradient.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cryohydrocytosis and familial pseudohyperkalemia</strong> – The findings in these two conditions are less well studied. One report of cryohydrocytosis reported a pattern similar to hereditary spherocytosis in sodium-containing buffer, with a leftward shift, whereas in cold potassium-containing buffer, there was an extremely abnormal pattern with the entire curve shifted rightward [<a href="#rid149">149</a>].</p><p></p><p class="bulletIndent1">Ektacytometry is also available in the United States in a limited number of laboratories. (See <a class="local">'Resources for testing'</a> below.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>RBC cation content measurements</strong> – These may be obtained for research but are not available as a clinical test.</p><p></p><p class="headingAnchor" id="H3622164627"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of HSt or HX is typically made by demonstrating anemia and/or chronic hemolysis associated with the characteristic changes in RBC morphology (stomatocytosis and/or xerocytosis) in conjunction with altered RBC indices such as elevated mean corpuscular hemoglobin concentration (MCHC), elevated mean corpuscular volume (MCV), and diagnostic changes on osmotic fragility testing or ektacytometry  (<a class="graphic graphic_algorithm graphicRef130750" href="/z/d/graphic/130750.html" rel="external">algorithm 1</a>). </p><p>The diagnostic workflow is described above. (See <a class="local">'Evaluation'</a> above.)</p><p>Up to one-third of patients do not have overt hemolysis, and lack of hemolysis does not eliminate the possibility of HSt or HX, especially if other features suggest one of these diagnoses [<a href="#rid1">1,112,146,150</a>].</p><p>In some cases, genetic testing may be used to establish the diagnosis, especially if a familial variant is known. If diagnostic changes are found on osmotic fragility testing or ektacytometry, genetic testing can be confirmatory but is not required. (See <a class="local">'Genetic testing'</a> below.)</p><p class="headingAnchor" id="H1729110874"><span class="h1">GENETIC TESTING</span></p><p class="headingAnchor" id="H3571822492"><span class="h2">Role of testing/which tests to perform</span><span class="headingEndMark"> — </span>The use of genetic testing is individualized based on the findings from red blood cell (RBC) osmotic fragility testing (to confirm the diagnosis if needed), as well as the clinical severity, family history, and possible need for prenatal testing of family members [<a href="#rid1">1,47</a>]. </p><p>However, genetic testing is not required for diagnosis, especially in patients who are asymptomatic and/or do not have evidence of ongoing hemolysis.</p><p>Some affected children will have a negative family history, and many of these will be found to have a new germline variant [<a href="#rid5">5</a>]. Thus, family history is more helpful if positive but cannot be used to exclude the diagnosis if negative. (See <a class="local">'Genetics'</a> above.)</p><p>The appropriate test depends on the clinical scenario (familial variant known, which disorder is suspected):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Known familial variant</strong> – When the familial variant is known, genetic testing can confirm the presence or absence of the variant in other family members. This is especially true for well-characterized variants with established pathogenicity. In these cases, the familial variant can be tested without the need for more extensive testing.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Suspected dehydrated HSt and HX</strong> – For suspected dehydrated HSt and HX, <em>PIEZO1</em> variants should be assessed, although some patients with these conditions may have negative DNA analysis. In <em>PIEZO1</em> variant-negative cases, Gardos channel (<em>KCNN4</em>) variants should be investigated.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Suspected overhydrated HSt</strong> – For suspected overhydrated HSt, testing should include <em>RHAG/SLC4A1 </em>and <em>SLC2A1</em>.</p><p></p><p>In some cases, a gene panel test may be more economical than single gene testing; if this is used, it is important to confirm that the desired gene(s) and variants in those genes are on the panel. (See  <a class="medical medical_review" href="/z/d/html/2901.html" rel="external">"Genetic testing", section on 'Extent of DNA analysis'</a>.)</p><p>If a new variant is identified and its pathogenicity is unknown, it generally must be evaluated functionally in a specialized research laboratory that has access to techniques such as patch clamp testing and cell culture. This is especially relevant for new <em>PIEZO1</em> variants, which exhibit a high degree of genetic polymorphism [<a href="#rid7">7,151,152</a>]. </p><p>Genetic testing may also be appropriate for some individuals who are considering splenectomy, especially if there is any doubt about the diagnosis. However, this testing may not be available for some patients.</p><p class="headingAnchor" id="H4184597287"><span class="h2">Genetic testing of family members</span><span class="headingEndMark"> — </span>We prefer to test all first-degree relatives of an individual with HSt or HX, if possible. Potential benefits of genetic testing include the ability to distinguish between affected and unaffected individuals in a family and identification of those who may require closer monitoring for hemolysis, especially at times of increased stress (eg, infections, hospitalizations), those who must avoid splenectomy, and those who may be at risk of iron overload due to the presence of the <em>HFE</em> C282Y variant. </p><p>In addition, information about the genetic defect may be useful for future enrollment in clinical trials and/or for use of investigational or newly developed therapies that target a specific genetic defect.</p><p>General discussions of genetic counseling for family members and genetic testing of children are available separately. (See  <a class="medical medical_review" href="/z/d/html/103304.html" rel="external">"Genetic counseling: Family history interpretation and risk assessment"</a> and  <a class="medical medical_review" href="/z/d/html/2901.html" rel="external">"Genetic testing", section on 'Ethical, legal, and psychosocial issues'</a>.)</p><p class="headingAnchor" id="H1905394074"><span class="h2">Resources for testing</span><span class="headingEndMark"> — </span>The following laboratories/experts serve as reference laboratories for the diagnosis of rare anemias including HSt and HX:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>United States</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Blood Disease Reference Laboratory, Department of Pathology</p><p class="bulletIndent2">310 Cedar Street, LH215</p><p class="bulletIndent2">New Haven, CT 06520</p><p class="bulletIndent2">Tel: 203-785-4492</p><p class="bulletIndent2">Fax: 203-785-3896</p><p class="bulletIndent2"><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fmedicine.yale.edu%2Fpathology%2Fclinical%2Fmdx%2F&amp;token=9ivqvfMXg3Xx9CVzOFyQMK7N6zwShyKzGB6KfJK%2F%2BqLPQmLVrbF2PknVE8dfRlyGFFjI2uHjPit03HJOHj3NCg%3D%3D&amp;TOPIC_ID=7068" target="_blank">https://medicine.yale.edu/pathology/clinical/mdx/</a></p><p class="bulletIndent2">Medical Director: Pei Hui, MD, PhD</p><p class="bulletIndent2">Laboratory Supervisor: Teresa Silva, e-mail: <a class="__cf_email__" data-cfemail="ccb8a9bea9bfade2bfa5a0baad8cb5ada0a9e2a9a8b9" href="/cdn-cgi/l/email-protection">[email protected]</a></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cancer and Blood Diseases Institute Erythrocyte Diagnostic Laboratory</p><p class="bulletIndent2">Cincinnati Children's Medical Center</p><p class="bulletIndent2">3333 Burnet Avenue, R1553</p><p class="bulletIndent2">Cincinnati, OH 45229-3039</p><p class="bulletIndent2">Tel: 513-636-4234</p><p class="bulletIndent2">Fax: 513-636-2106</p><p class="bulletIndent2"><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cincinnatichildrens.org%2Fservice%2Fc%2Fcancer-blood%2Fhcp%2Fclinical-laboratories%2Ferythrocyte-diagnostic-lab&amp;token=bAo6sY1hY3mZukqj2l4FwYv5%2FnnHo7EmecoqokHcTM5M14FY%2B33kVzlWYLtbqCq%2Btxaz89PV4alDxVSjekXqo8uW9xnnuJw7kHxHI%2FpxP2HSM09wAGu8gMa6YCg6wLBc&amp;TOPIC_ID=7068" target="_blank">https://www.cincinnatichildrens.org/service/c/cancer-blood/hcp/clinical-laboratories/erythrocyte-diagnostic-lab</a></p><p class="bulletIndent2">E-mail: <a class="__cf_email__" data-cfemail="d9b1bcb4b6beb5b6bbb0b799babab1b4baf7b6abbe" href="/cdn-cgi/l/email-protection">[email protected]</a></p><p class="bulletIndent2">Medical Directors: Charles T Quinn, MDS and Theodosia Kalfa, MD, PhD</p><p class="bulletIndent2">Laboratory Supervisor: Mary Reynaud, e-mail: <a class="__cf_email__" data-cfemail="4e232f3c37603c2b37202f3b2a0e2d2d26232d60213c29" href="/cdn-cgi/l/email-protection">[email protected]</a></p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Europe</strong> – An updated list of investigators and laboratories can be found on websites such as:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>European Network for Rare and Congenital Anemias (ENERCA)</p><p class="bulletIndent2"><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fenerca.org%2F&amp;token=1PW0zPbSXCcZRHgBjLmZmdR%2BhLMJ%2FsDzdaEk1befkKI%3D&amp;TOPIC_ID=7068" target="_blank">enerca.org</a> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Orphanet portal</p><p class="bulletIndent2"><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.orpha.net%2Fconsor4.01%2Fwww%2Fcgi-bin%2FClinics.php%3Flng%3DIT&amp;token=mJ2XuLqdLLe0%2BA8rZisyxjBn7GvSWxzUEEl7L6E2%2ByFVE3Ytle8BoyevP0dz7f3v6OA7g03ofxOgqSgVrXk4Bd199d0v%2FMOUzIjkllVoYE4%3D&amp;TOPIC_ID=7068" target="_blank">https://www.orpha.net/consor4.01/www/cgi-bin/Clinics.php?lng=IT</a></p><p></p><p class="bulletIndent1">Specific laboratories in Europe that perform ektacytometry include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>CEINGE biotecnologie avanzate Franco Salvatore, Naples Italy (Proff. A. Iolascon, I. Andolfo, R. Russo) </p><p class="bulletIndent2">Email: <a class="__cf_email__" data-cfemail="fa9397979b9995969b8e9bd49b949e95969c95ba8f9493949bd4938e" href="/cdn-cgi/l/email-protection">[email protected]</a></p><p class="bulletIndent2"><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fnam04.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.ceinge.unina.it%252Findex.php%252Fbioingegneria%26data%3D05%7C01%7CJennifer.Tirnauer%2540wolterskluwer.com%7Cb137e76d0cf5477bdca108dbce37b4c3%7C8ac76c91e7f141ffa89c3553b2da2c17%7C0%7C0%7C638330510888369281%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%7C3000%7C%7C%7C%26sdata%3DpJfmSPwA5qbazc0CH2U%252BkZrlDpXXgOmSaufYTk%252Bkklg%253D%26reserved%3D0&amp;token=viQRLBFrHoaqv4lsN4JIAmeo%2BN4KpAklCYHHuNdLCuwfeyY4zxeqs1KtOV5ZMq581bUjVdqJ6pFMVpXxZ%2FFlDgQdwpdI0nXlncTfIkPPhDOJFNM%2BYl04dFNBezlps7%2BkKj6kYVCzvsiNolMwwsFMr1PMK3lKRS90MnWqo1bcWcr1E%2FaUKZbZYg%2ByJOUtg8hiqSI5ls0suTdZa8ngxjgXHo2O7D3yGJp4toPOjYGQwDCmPltTrxoSobUxzrc59srDzf5kS%2FH7yB2RHQdrFsKNESf0JBOYuyrLqb6m2kpgOMd4RkOi12hrYduVCbAfSLJ1GaP5O9AGtfXtMaLnNXVmJ55RxKjOIiseAGf3dVjsY9e0E3qrDSpoBWa6CnqYNLJD0CwIV0HbHrFuqGZD3yQbJ%2FU%2Baaq8JRghckzTfPKBswuiNV7DVlO7slI0H%2FLlC283rwC1JCwUsNIWoeWxLU0oqw%3D%3D&amp;TOPIC_ID=7068" target="_blank">https://www.ceinge.unina.it/index.php/bioingegneria</a></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy (Dr. P. Bianchi)</p><p class="bulletIndent2">Email: <a class="__cf_email__" data-cfemail="4535242a29246b272c242b262d2c05352a292c26292c2b2c262a6b282c6b2c31" href="/cdn-cgi/l/email-protection">[email protected]</a></p><p class="bulletIndent2"><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fnam04.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.policlinico.mi.it%252Fi-nostri-professionisti%252Fprofilo%252F1015%252Fbianchi-paola%26data%3D05%7C01%7CJennifer.Tirnauer%2540wolterskluwer.com%7Cb137e76d0cf5477bdca108dbce37b4c3%7C8ac76c91e7f141ffa89c3553b2da2c17%7C0%7C0%7C638330510888369281%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%7C3000%7C%7C%7C%26sdata%3Dj8nCp%252FhhAR%252B4UgKlVEFdZXloihjejs%252BTWzOiFBYLy%252Fw%253D%26reserved%3D0&amp;token=U3okkUbX90aid0Ukt9io2LXgblehWbFOCQB4DTKbyiLnKGoJl7itagtw1OsdiSjoUeBW8YshMFKOtz7d4PPd7AelrembEnIpowSNicPkRKc4qtzsOd2%2Fpt3hkDv1j8xKMiFiooWZFKDrfhiwpX5uizZrhwv%2FvYZ05ah5EAmP4oxSEO7iPerQtrsDrhbwhcUaBV0SVm0L6gLfJ5LRn9nkV8tO62LdSkiaF56XYsz5lJpdEg6hTNPqyWYnU8licgZ%2FKf7BpyrW4J5J5iQ2hnulRmhCHiQQH5MVnQrhqBaECwAPBLKv5Ld994wEjPv7Uy8NtC164LLjIlilyjDAHiKHOWxe7CNfm8Vu80plmixuwFAXJz7mCoyUbQ03vBwXWV9sV5y80YM2whiYGW8gXh66v2q7HMwJkQumedhH9uTjLtb7qwRU%2B6XG87lrV7Jtq%2Be8PgRwuobawBQyIYz93fbrmZwzUPSMddTF3C9cw%2FkBYik%3D&amp;TOPIC_ID=7068" target="_blank">https://www.policlinico.mi.it/i-nostri-professionisti/profilo/1015/bianchi-paola</a></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>University Medical Center Utrecht, Netherlands (Prof. R. Van Wijk)</p><p class="bulletIndent2">Email: <a class="__cf_email__" data-cfemail="f6a4d8809798a19f9c9db6839b9583828493959e82d8989a" href="/cdn-cgi/l/email-protection">[email protected]</a></p><p class="bulletIndent2"><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fnam04.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.umcutrecht.nl%252Fen%252Fresearch%252Fresearchers%252Fvan-wijk-richard-ha%2523%26data%3D05%7C01%7CJennifer.Tirnauer%2540wolterskluwer.com%7Cb137e76d0cf5477bdca108dbce37b4c3%7C8ac76c91e7f141ffa89c3553b2da2c17%7C0%7C0%7C638330510888369281%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%7C3000%7C%7C%7C%26sdata%3DD76%252FVwMRurGu80I93QPHoSeuDUHJDe8CI4VMa%252B5kbqw%253D%26reserved%3D0&amp;token=z8RGMml1zxl0gKjBlIyXP0tNHPguC8jNzerNfQlzlofTQjSpez%2BsE99eU05dxabx7hh0e%2FfQyHXf0NBuLWoPDD55YxXJoxen8viGByErofthJazkOHq7OpeuLyH4xmYpSg9o9i%2FDlVrY7A5i0WvS5jlEO8Diqk9p6EjsskLaxSpaS6FT9lLLfZtmDGDMuZnpcimuBeMv4wysAsnvKl6AsopmxVDiUR64E3Gqku9iNc%2FzsuQZjcuil25LGLTuTePc57iNYal8JcMaMWGMwsFRpxDa2WdG0ObGI%2BwYqkbqvmWQXixcuFotleV9Z1Q%2F%2B1ofF8bePsRoh90OVJYdqO%2Fa%2FToBwwwWX2doVrr%2Fecuy2IJ%2BxXJCWxJmSa7BW2NezPIcUs9XN3hM4XJYKLwufebzVzKVujsuEcB3ubKC1kB5L5broyTustMwtW9dQPc2c%2FURQ81P7CNP6WiH0JzNqYo4sg%3D%3D&amp;TOPIC_ID=7068" target="_blank">https://www.umcutrecht.nl/en/research/researchers/van-wijk-richard-ha#</a></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>INSERM U1134, INTS, Paris, France (Dr. Loïc Garçon) </p><p></p><p class="headingAnchor" id="H1905394086"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of HSt and HX includes a variety of other inherited and acquired conditions that cause hemolytic anemia and/or red blood cell (RBC) morphologic abnormalities. </p><p class="headingAnchor" id="H2306113878"><span class="h2">Hemolytic anemias</span><span class="headingEndMark"> — </span>There are numerous other causes of hemolytic anemia. The most likely causes differ by age, ethnic background, and presence of other medical conditions. The figure shows a conceptual framework for these disorders  (<a class="graphic graphic_figure graphicRef117376" href="/z/d/graphic/117376.html" rel="external">figure 4</a>).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hereditary enzyme disorders</strong> – Some hemolytic anemias are inherited RBC enzymatic deficiencies such as glucose-6-phosphate dehydrogenase (G6PD) deficiency or pyruvate kinase (PK) deficiency. Less common RBC enzyme disorders are also possible. (See  <a class="medical medical_review" href="/z/d/html/7111.html" rel="external">"Diagnosis and management of glucose-6-phosphate dehydrogenase (G6PD) deficiency"</a> and  <a class="medical medical_review" href="/z/d/html/7129.html" rel="external">"Pyruvate kinase deficiency"</a> and  <a class="medical medical_review" href="/z/d/html/7128.html" rel="external">"Rare RBC enzyme disorders"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hereditary spherocytosis</strong> – Membrane/cytoskeletal disorders include hereditary spherocytosis (HS) and others. In addition to morphologic differences, there are differences in the genetics and specialized testing. As an example, HS is associated with gene variants affecting band 3 and others. RBCs in HS show increased (incubated) osmotic fragility, as well as decreased eosin-5-maleimide (EMA) binding and a positive acidified glycerol lysis (AGLT) test for lysis in &lt;900 seconds. In contrast, in most cases of HSt, EMA binding is normal or increased and the AGLT is negative [<a href="#rid5">5</a>]. (See  <a class="medical medical_review" href="/z/d/html/7079.html" rel="external">"Hereditary spherocytosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>CDAs</strong> – Congenital dyserythropoietic anemias (mainly CDAI and CDAII) are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5931.html" rel="external">"Overview of causes of anemia in children due to decreased red blood cell production", section on 'Congenital dyserythropoietic anemia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acquired disorders </strong>– Other disorders are acquired; some may be immune mediated, such as hemolytic disease of the fetus and newborn (HDFN) or paroxysmal nocturnal hemoglobinuria (PNH). (See  <a class="medical medical_review" href="/z/d/html/5933.html" rel="external">"Alloimmune hemolytic disease of the newborn: Postnatal diagnosis and management"</a> and  <a class="medical medical_review" href="/z/d/html/7159.html" rel="external">"Clinical manifestations and diagnosis of paroxysmal nocturnal hemoglobinuria"</a>.)</p><p></p><p>Like HSt and HX, these conditions may have anemia and laboratory findings consistent with hemolysis. Unlike HSt and HX, they typically have differing RBC morphologies on the peripheral blood smear (in HS, predominance of spherocytes rather than stomatocytes or xerocytes), and specialized testing in these other conditions will reveal the alternative diagnosis. </p><p class="headingAnchor" id="H1914042753"><span class="h2">Other causes of stomatocytosis</span><span class="headingEndMark"> — </span>A number of other inherited and acquired disorders may be associated with stomatocytes on the peripheral blood smear. These conditions are distinguished from HSt by review of the clinical scenario and specialized laboratory testing. An approach to determining the cause of stomatocytosis or a high MCHC is illustrated in the algorithm  (<a class="graphic graphic_algorithm graphicRef130750" href="/z/d/graphic/130750.html" rel="external">algorithm 1</a>). </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hereditary</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>SAO</strong> – Southeast Asian ovalocytosis (SAO) is a heritable RBC disorder caused by pathogenic variants affecting band 3; it is most frequently seen in individuals from parts of Southeast Asia, including Malaysia, New Guinea, Indonesia, and the Philippines. Like HSt, in SAO the cells have an oval or elliptocytic shape on the blood smear, often with one or two longitudinal slits. Unlike HSt, in SAO there is a specific deletion in the <em>SLC4A1</em> gene, and hemolytic anemia typically is not seen after three years of age in individuals with SAO. (See  <a class="medical medical_review" href="/z/d/html/142822.html" rel="external">"Southeast Asian ovalocytosis (SAO)", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Rh null disease</strong> – Complete deficiency of Rh antigens on the RBC surface (Rh null disease) causes hemolytic anemia of variable clinical severity, stomatocytosis, and, with continuing loss of membrane, hyperdense spherocytes with increased osmotic fragility. Patients may be identified during pretransfusion testing. The diagnosis is made by demonstrating that all antigens of the Rh system are absent from the RBC surface [<a href="#rid153">153</a>]. (See  <a class="medical medical_review" href="/z/d/html/7924.html" rel="external">"Red blood cell antigens and antibodies", section on 'Rh blood group system'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Tangier disease</strong> – Tangier disease is an autosomal recessive disorder associated with a derangement in cholesterol metabolism, characterized by hypertriglyceridemia, very low levels of high-density lipoprotein, and increased deposition of cholesterol esters in tissues and in phagocytic cells [<a href="#rid154">154</a>]. Tangier disease may be associated with hemolysis, and in one patient, was characterized by stomatocytosis and increased osmotic fragility [<a href="#rid155">155</a>]. The abnormal membrane lipids may be responsible for the stomatocytosis, as described below for stomatocytosis in the setting of acquired stomatocytosis. (See  <a class="medical medical_review" href="/z/d/html/4560.html" rel="external">"HDL cholesterol: Clinical aspects of abnormal values", section on 'Inherited causes'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Phytosterolemia</strong> – Phytosterolemia (also called sitosterolemia or Mediterranean stomatocytosis/macrothrombocytopenia) is a rare inherited metabolic condition that affects intestinal absorption of cholesterol and plant sterols [<a href="#rid10">10,156,157</a>]. This in turn alters the membrane composition of RBCs as well as other cells such as platelets. Patients may have hemolytic anemia, stomatocytosis, and thrombocytopenia with increased platelet volume [<a href="#rid5">5,158</a>]. (See  <a class="medical medical_review" href="/z/d/html/4565.html" rel="external">"Lipoprotein classification, metabolism, and role in atherosclerosis", section on 'Exogenous pathway of lipid metabolism'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acquired </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Liver disease/alcohol</strong> – Stomatocytes can be seen with chronic liver disease (most often due to excess alcohol use) or acute alcohol intoxication [<a href="#rid159">159</a>]. The stomatocytosis with acute alcohol intoxication appears to be transient, and it may affect a significant proportion of RBCs [<a href="#rid159">159,160</a>]. In one series of 100 patients admitted to a general medical ward with alcohol intoxication, 15 percent had ≥10 percent stomatocytes and another 29 percent had 5 to 9 percent stomatocytes on the peripheral blood smear [<a href="#rid159">159</a>]. The mechanism is thought to be due to a reduction in RBC membrane surface area rather than an increase in RBC volume. (See <a class="local">'Stomatocyte formation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Medications </strong>– Some medications can cause transient stomatocytosis [<a href="#rid161">161</a>]. One study demonstrated formation of stomatocytes upon exposure of RBCs to the chemotherapeutic drug <a class="drug drug_general" data-topicid="10044" href="/z/d/drug information/10044.html" rel="external">vinblastine</a> and the antipsychotic agent <a class="drug drug_general" data-topicid="9252" href="/z/d/drug information/9252.html" rel="external">chlorpromazine</a> [<a href="#rid162">162</a>]. Intercalation of the drug into the inner half of the lipid bilayer may be responsible for creating the abnormal morphology. (See <a class="local">'Stomatocyte formation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>In vitro artifact</strong> – Stomatocytosis also can result as a drying artifact or peripheral blood smear preparation. (See <a class="local">'Stomatocyte formation'</a> above.)</p><p></p><p class="headingAnchor" id="H2828080633"><span class="h2">Other causes of xerocytosis</span><span class="headingEndMark"> — </span>Several other conditions are associated with xerocytes (or dense, hyperchromic cells resembling xerocytes) on the peripheral blood smear, with an increased mean corpuscular hemoglobin concentration (MCHC). These include hereditary elliptocytosis (HE) and hemoglobinopathies such as sickle cell disease (SCD) and homozygous hemoglobin C disease (Hb CC). In contrast, thalassemia is not associated with xerocytes; in thalassemia, the MCHC is reduced rather than increased.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>SCD </strong>– Cell dehydration is a characteristic feature of the RBCs in sickle cell disease (SCD) [<a href="#rid163">163,164</a>]. Morphology of the cells differs from xerocytes because of the prominent sickled shape  (<a class="graphic graphic_picture graphicRef64449" href="/z/d/graphic/64449.html" rel="external">picture 5</a>), but the changes in cellular properties show some overlap with xerocytes. The mechanism of cell dehydration in SCD involves loss of intracellular K<sup>+</sup> due to alterations in K<sup>+</sup>-Cl<sup>-</sup> transport and/or alterations in the Ca<sup>++</sup>-sensitive K<sup>+</sup> channel (Gardos channel) [<a href="#rid165">165,166</a>]. This is most likely due to interaction of sickle hemoglobin (Hb S) with the cell membrane or the regulatory machinery of the transporter [<a href="#rid99">99</a>]. These dense, dehydrated cells play an important role in pathogenesis of the vaso-occlusive manifestations of the disease [<a href="#rid167">167-170</a>]. (See  <a class="medical medical_review" href="/z/d/html/7135.html" rel="external">"Pathophysiology of sickle cell disease", section on 'Membrane damage'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hb CC</strong> – Cell dehydration is a characteristic feature of homozygous Hb C (Hb CC) disease, which in most cases is characterized by a mild, compensated hemolysis with no significant anemia. The blood smear may show dehydrated cells and target cells  (<a class="graphic graphic_picture graphicRef61082" href="/z/d/graphic/61082.html" rel="external">picture 6</a>). Dehydration may be related to abnormal cell K<sup>+</sup> loss via K<sup>+</sup>-Cl<sup>-</sup> cotransport as well as a possible interaction between the abnormally positively charged hemoglobin protein and the cell membrane [<a href="#rid90">90,99,101,171,172</a>]. (See  <a class="medical medical_review" href="/z/d/html/7127.html" rel="external">"Hemoglobin variants including Hb C, Hb D, and Hb E", section on 'Hb C'</a>.)</p><p></p><p class="headingAnchor" id="H3404392377"><span class="h2">Infantile pyknocytosis</span><span class="headingEndMark"> — </span>Pyknocytes are hyperdense, dehydrated RBCs with irregular borders and varying numbers of projections. Infantile pyknocytosis is a condition that occurs in neonates, characterized by transient, non-immune hemolytic anemia that resolves in infancy. The cause (and whether it is due to a genetic or environmental factor) is unknown [<a href="#rid173">173,174</a>]. </p><p>In one series that analyzed blood samples from 149 neonates with unexplained hemolytic anemia, pyknocytes were seen in 14 (9 percent) [<a href="#rid175">175</a>]. Pyknocytes may also be seen in individuals with HE, in whom the elliptocytes may not appear until later in life. Like HSt and HX, infantile pyknocytosis can present with hemolytic anemia in infancy. Unlike HSt and HX, infantile pyknocytosis resolves within the first year of life, and the cause is unknown.</p><p class="headingAnchor" id="H1905394316"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>Limited data are available on the management of HSt and HX. In general, management is individualized according to the severity of hemolytic anemia.</p><p>The value of genetic counseling and testing first-degree relatives is discussed above. (See <a class="local">'Genetic testing of family members'</a> above.)</p><p class="headingAnchor" id="H543568115"><span class="h2">Management of hemolysis/hemolytic anemia</span><span class="headingEndMark"> — </span>Individuals without baseline hemolysis may not require any interventions. However, awareness of the diagnosis may be helpful if they are hospitalized for an acute illness or if they develop an infection that tips the balance between hemolysis and reticulocytosis.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Folate supplementation</strong> – Folate supplementation (typically 1 mg orally per day) is appropriate in individuals with chronic hemolysis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transfusions</strong> – Patients with mild or no hemolytic anemia are unlikely to require RBC transfusions. However, transfusions (or exchange transfusions in neonates) may be required in the setting of severe hemolysis. Chronic transfusions are rarely required; the need for chronic transfusions suggests that the original diagnosis may require re-evaluation or that another cause of anemia may have developed in addition to HSt or HX.</p><p></p><p class="bulletIndent1">Additional information is presented separately according to patient age. (See  <a class="medical medical_review" href="/z/d/html/5041.html" rel="external">"Red blood cell (RBC) transfusions in the neonate"</a> and  <a class="medical medical_review" href="/z/d/html/5910.html" rel="external">"Red blood cell transfusion in infants and children: Indications"</a> and  <a class="medical medical_review" href="/z/d/html/7948.html" rel="external">"Indications and hemoglobin thresholds for RBC transfusion in adults"</a>.)</p><p></p><p class="headingAnchor" id="H1854150238"><span class="h2">Assessment of iron status</span><span class="headingEndMark"> — </span>Assessment for iron overload is appropriate in individuals with chronic hemolysis. This is especially important for individuals who have received multiple transfusions; however, iron overload can also occur in the absence of transfusions due to chronic hemolytic anemia. (See <a class="local">'Clinical manifestations'</a> above.)</p><p>Typically, serum iron, ferritin, and transferrin saturation (TSAT; the ratio of iron to transferrin) are measured at the time of diagnosis, with subsequent annual monitoring and testing based on the initial values. Individuals with evidence of iron overload may also have testing for hereditary hemochromatosis (HH) <em>HFE</em> C282Y variant. For patients with HX who are not significantly anemic and who carry a genetic predisposition to iron overload, phlebotomy may be appropriate when ferritin levels are significantly elevated. (See  <a class="medical medical_review" href="/z/d/html/7157.html" rel="external">"Approach to the patient with suspected iron overload"</a>.)</p><p class="headingAnchor" id="H1164056102"><span class="h2">Gallstones</span><span class="headingEndMark"> — </span>Patients should be aware of the possibility of pigment gallstones and the typical symptoms. </p><p>Evaluation for symptoms is appropriate; however, we do not screen asymptomatic individuals in most cases. </p><p>Assessment for and management of gallstones depends on clinical features and severity of the findings. Details are presented in separate topic reviews. (See  <a class="medical medical_review" href="/z/d/html/13922.html" rel="external">"Choledocholithiasis: Clinical manifestations, diagnosis, and management"</a> and  <a class="medical medical_review" href="/z/d/html/673.html" rel="external">"Approach to the management of gallstones"</a> and  <a class="medical medical_review" href="/z/d/html/15095.html" rel="external">"Gallstone diseases in pregnancy"</a>.)</p><p class="headingAnchor" id="H3219228103"><span class="h2">Splenectomy</span><span class="headingEndMark"> — </span>Splenectomy has been performed in individuals with severe hemolysis. However, there is limited evidence of therapeutic benefit, and the procedure has risks, including those associated with the surgery, risk of infection with encapsulated organisms, and risk of thromboembolism. </p><p>Thus, we generally reserve splenectomy as a last resort for patients who are severely symptomatic from splenomegaly. We do not perform splenectomy in the vast majority of patients with HSt or HX. If performed, splenectomy should be undertaken with extreme caution, especially in individuals carrying a <em>PIEZO1</em> variant, as thrombotic complications following splenectomy have been mostly described in individuals with <em>PIEZO1</em> variants [<a href="#rid137">137</a>]. </p><p>Individuals with HSt or HX who undergo splenectomy have a much greater risk of vascular complications including thromboembolic events and/or vaso-occlusive episodes [<a href="#rid65">65,117,124</a>]. Several case reports describe development of pulmonary hypertension due to multiple thromboemboli following splenectomy in HSt [<a href="#rid65">65,117</a>]. (See <a class="local">'Other findings'</a> above.)</p><p>Additional pre-splenectomy considerations are presented separately. (See  <a class="medical medical_review" href="/z/d/html/117640.html" rel="external">"Elective (diagnostic or therapeutic) splenectomy"</a> and  <a class="medical medical_review" href="/z/d/html/1412.html" rel="external">"Prevention of infection in patients with impaired splenic function"</a>.)</p><p class="headingAnchor" id="H3394069467"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/111043.html" rel="external">"Society guideline links: Anemia in adults"</a>.)</p><p class="headingAnchor" id="H1905395528"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definitions</strong> – Stomatocytes are red blood cells (RBCs) with a mouth-shaped area of central pallor  (<a class="graphic graphic_picture graphicRef75535" href="/z/d/graphic/75535.html" rel="external">picture 1</a>) caused by conversion of the biconcave disc to a uniconcave cup  (<a class="graphic graphic_picture graphicRef130751" href="/z/d/graphic/130751.html" rel="external">picture 2</a>). Xerocytes are dense, hyperchromic RBCs with an elevated mean cell hemoglobin concentration (MCHC)  (<a class="graphic graphic_picture graphicRef62761" href="/z/d/graphic/62761.html" rel="external">picture 3</a>). Hereditary stomatocytosis (HSt) and hereditary xerocytosis (HX) have been classified according to RBC appearance and the degree of cell hydration. (See <a class="local">'Definitions and classification'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genetics</strong> – HSt and HX are typically autosomal dominant. Some cases of HSt and HX are caused by pathogenic variants in the <em>PIEZO1</em> gene, which encodes a mechanosensitive ion channel. Some cases of dehydrated HSt are caused by pathogenic variants in <em>KCNN4</em>, which encodes the Gardos channel. Other implicated genes include <em>RHAG</em> and <em>SCL4A1/BAND3/AE1</em>. (See <a class="local">'Genetics'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Disease mechanisms</strong> – Several ion transport systems continuously regulate RBC water, cation, and anion content  (<a class="graphic graphic_figure graphicRef62852" href="/z/d/graphic/62852.html" rel="external">figure 1</a>). Stomatocytes and xerocytes form when changes in RBC cation content cause compensatory changes in cell water  (<a class="graphic graphic_figure graphicRef55556" href="/z/d/graphic/55556.html" rel="external">figure 2</a>). The resulting decrease in deformability of the RBCs predisposes them to hemolysis. The table summarizes other disorders of RBC volume  (<a class="graphic graphic_table graphicRef80358" href="/z/d/graphic/80358.html" rel="external">table 1</a>). (See <a class="local">'Pathophysiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Typical findings</strong> – HSt and HX cause variable compensated hemolysis and hemolytic anemia, with abnormal RBC morphologies. Iron overload can occur, even without transfusions. Some individuals develop splenomegaly and/or pigment gallstones. Some have an increased risk of vascular and/or thromboembolic complications. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic testing</strong> – The diagnosis may be suspected due to a positive family history, unexplained non-immune hemolysis, unexplained elevated MCHC and mean corpuscular hemoglobin (MCH), or stomatocytes or xerocytes on the blood smear. Testing proceeds sequentially. All individuals should have a review of the complete blood count (CBC), RBC indices, and blood smear, and testing for hemolysis, including a direct antiglobulin test (DAT; Coombs test). For those with suggestive findings, additional testing includes osmotic fragility, ektacytometry, and/or genetic testing. Resources for obtaining this testing are listed above. (See <a class="local">'Evaluation'</a> above and <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The differential diagnosis includes other inherited hemolytic anemias  (<a class="graphic graphic_figure graphicRef117376" href="/z/d/graphic/117376.html" rel="external">figure 4</a>), other inherited causes of stomatocytosis such as Southeast Asian ovalocytosis, acquired causes of stomatocytosis (liver disease, alcohol, medications), and infantile pyknocytosis. An approach to determining the cause of stomatocytosis or a high MCHC is illustrated in the algorithm  (<a class="graphic graphic_algorithm graphicRef130750" href="/z/d/graphic/130750.html" rel="external">algorithm 1</a>). (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – Management is individualized according to the severity of hemolysis. Those with chronic hemolysis are given <a class="drug drug_general" data-topicid="8475" href="/z/d/drug information/8475.html" rel="external">folic acid</a>. Transfusions may be needed intermittently. Monitoring for iron overload is appropriate. Symptomatic gallstones should be evaluated and treated. (See <a class="local">'Management of hemolysis/hemolytic anemia'</a> above and <a class="local">'Assessment of iron status'</a> above and <a class="local">'Gallstones'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Role of splenectomy</strong> – Evidence for improvement with splenectomy is limited, and severe complications including thromboembolic events and pulmonary hypertension have been reported, especially in individuals with pathogenic variants in <em>PIEZO1</em>. Postoperative infection and surgical complications can occur. We generally reserve splenectomy for patients with severe hemolysis or severe symptoms related to splenomegaly; for those with <em>PIEZO1</em> variants, we recommend not performing splenectomy (<a class="grade" href="https:///uptodate/show/grade_3" rel="external">Grade 1C</a>). (See <a class="local">'Splenectomy'</a> above.)</p><p></p><p class="headingAnchor" id="H1151787792"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges extensive contributions of Donald H Mahoney, Jr, MD, to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Andolfo I, Russo R, Gambale A, Iolascon A. Hereditary stomatocytosis: An underdiagnosed condition. Am J Hematol 2018; 93:107.</a></li><li><a class="nounderline abstract_t">Clark MR, Shohet SB, Gottfried EL. Hereditary hemolytic disease with increased red blood cell phosphatidylcholine and dehydration: one, two, or many disorders? Am J Hematol 1993; 42:25.</a></li><li><a class="nounderline abstract_t">Stewart GW. The membrane defect in hereditary stomatocytosis. Baillieres Clin Haematol 1993; 6:371.</a></li><li><a class="nounderline abstract_t">Flatt JF, Bruce LJ. The hereditary stomatocytoses. Haematologica 2009; 94:1039.</a></li><li><a class="nounderline abstract_t">King MJ, Garçon L, Hoyer JD, et al. ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders. Int J Lab Hematol 2015; 37:304.</a></li><li><a class="nounderline abstract_t">Andolfo I, Russo R, Rosato BE, et al. Genotype-phenotype correlation and risk stratification in a cohort of 123 hereditary stomatocytosis patients. Am J Hematol 2018; 93:1509.</a></li><li><a class="nounderline abstract_t">Rotordam MG, Fermo E, Becker N, et al. A novel gain-of-function mutation of Piezo1 is functionally affirmed in red blood cells by high-throughput patch clamp. Haematologica 2019; 104:e179.</a></li><li><a class="nounderline abstract_t">Bawazir WM, Gevers EF, Flatt JF, et al. An infant with pseudohyperkalemia, hemolysis, and seizures: cation-leaky GLUT1-deficiency syndrome due to a SLC2A1 mutation. J Clin Endocrinol Metab 2012; 97:E987.</a></li><li><a class="nounderline abstract_t">Flatt JF, Guizouarn H, Burton NM, et al. Stomatin-deficient cryohydrocytosis results from mutations in SLC2A1: a novel form of GLUT1 deficiency syndrome. Blood 2011; 118:5267.</a></li><li><a class="nounderline abstract_t">Rees DC, Iolascon A, Carella M, et al. Stomatocytic haemolysis and macrothrombocytopenia (Mediterranean stomatocytosis/macrothrombocytopenia) is the haematological presentation of phytosterolaemia. Br J Haematol 2005; 130:297.</a></li><li><a class="nounderline abstract_t">Kaya Z, Niu DM, Yorulmaz A, et al. A novel mutation of ABCG5 gene in a Turkish boy with phytosterolemia presenting with macrotrombocytopenia and stomatocytosis. Pediatr Blood Cancer 2014; 61:1457.</a></li><li><a class="nounderline abstract_t">Wang G, Cao L, Wang Z, et al. Macrothrombocytopenia/stomatocytosis specially associated with phytosterolemia. Clin Appl Thromb Hemost 2012; 18:582.</a></li><li><a class="nounderline abstract_t">Bae C, Gnanasambandam R, Nicolai C, et al. Xerocytosis is caused by mutations that alter the kinetics of the mechanosensitive channel PIEZO1. Proc Natl Acad Sci U S A 2013; 110:E1162.</a></li><li><a class="nounderline abstract_t">Faucherre A, Kissa K, Nargeot J, et al. Piezo1 plays a role in erythrocyte volume homeostasis. Haematologica 2014; 99:70.</a></li><li><a class="nounderline abstract_t">Archer NM, Shmukler BE, Andolfo I, et al. Hereditary xerocytosis revisited. Am J Hematol 2014; 89:1142.</a></li><li><a class="nounderline abstract_t">Zarychanski R, Schulz VP, Houston BL, et al. Mutations in the mechanotransduction protein PIEZO1 are associated with hereditary xerocytosis. Blood 2012; 120:1908.</a></li><li><a class="nounderline abstract_t">Andolfo I, Alper SL, De Franceschi L, et al. Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1. Blood 2013; 121:3925.</a></li><li><a class="nounderline abstract_t">Albuisson J, Murthy SE, Bandell M, et al. Dehydrated hereditary stomatocytosis linked to gain-of-function mutations in mechanically activated PIEZO1 ion channels. Nat Commun 2013; 4:1884.</a></li><li><a class="nounderline abstract_t">Glogowska E, Schneider ER, Maksimova Y, et al. Novel mechanisms of PIEZO1 dysfunction in hereditary xerocytosis. Blood 2017; 130:1845.</a></li><li><a class="nounderline abstract_t">Layton DM, Bain BJ. Dehydrated hereditary stomatocytosis. Am J Hematol 2016; 91:266.</a></li><li><a class="nounderline abstract_t">Nakahara E, Yamamoto KS, Ogura H, et al. Variant spectrum of PIEZO1 and KCNN4 in Japanese patients with dehydrated hereditary stomatocytosis. Hum Genome Var 2023; 10:8.</a></li><li><a class="nounderline abstract_t">Pérès L, Monedero Alonso D, Nudel M, et al. Characterisation of Asp669Tyr Piezo1 cation channel activity in red blood cells: an unexpected phenotype. Br J Haematol 2021; 194:e51.</a></li><li><a class="nounderline abstract_t">Caulier A, Jankovsky N, Demont Y, et al. PIEZO1 activation delays erythroid differentiation of normal and hereditary xerocytosis-derived human progenitor cells. Haematologica 2020; 105:610.</a></li><li><a class="nounderline abstract_t">Moura PL, Hawley BR, Dobbe JGG, et al. PIEZO1 gain-of-function mutations delay reticulocyte maturation in hereditary xerocytosis. Haematologica 2020; 105:e268.</a></li><li><a class="nounderline abstract_t">Fermo E, Vercellati C, Marcello AP, et al. Hereditary Xerocytosis due to Mutations in PIEZO1 Gene Associated with Heterozygous Pyruvate Kinase Deficiency and Beta-Thalassemia Trait in Two Unrelated Families. Case Rep Hematol 2017; 2017:2769570.</a></li><li><a class="nounderline abstract_t">Andolfo I, Martone S, Rosato BE, et al. Complex Modes of Inheritance in Hereditary Red Blood Cell Disorders: A Case Series Study of 155 Patients. Genes (Basel) 2021; 12.</a></li><li><a class="nounderline abstract_t">Yang E, Voelkel EB, Lezon-Geyda K, et al. Hemoglobin C trait accentuates erythrocyte dehydration in hereditary xerocytosis. Pediatr Blood Cancer 2017; 64.</a></li><li><a class="nounderline abstract_t">Pinto VM, Russo R, Quintino S, et al. Coinheritance of PIEZO1 variants and multi-locus red blood cell defects account for the symptomatic phenotype in beta-thalassemia carriers. Am J Hematol 2023; 98:E130.</a></li><li><a class="nounderline abstract_t">Ma S, Cahalan S, LaMonte G, et al. Common PIEZO1 Allele in African Populations Causes RBC Dehydration and Attenuates Plasmodium Infection. Cell 2018; 173:443.</a></li><li><a class="nounderline abstract_t">Ilboudo Y, Bartolucci P, Rivera A, et al. Genome-wide association study of erythrocyte density in sickle cell disease patients. Blood Cells Mol Dis 2017; 65:60.</a></li><li><a class="nounderline abstract_t">Karamatic Crew V, Tilley LA, Satchwell TJ, et al. Missense mutations in PIEZO1, which encodes the Piezo1 mechanosensor protein, define Er red blood cell antigens. Blood 2023; 141:135.</a></li><li><a class="nounderline abstract_t">GARDOS G. The function of calcium in the potassium permeability of human erythrocytes. Biochim Biophys Acta 1958; 30:653.</a></li><li><a class="nounderline abstract_t">Ishii TM, Silvia C, Hirschberg B, et al. A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci U S A 1997; 94:11651.</a></li><li><a class="nounderline abstract_t">Vandorpe DH, Shmukler BE, Jiang L, et al. cDNA cloning and functional characterization of the mouse Ca2+-gated K+ channel, mIK1. Roles in regulatory volume decrease and erythroid differentiation. J Biol Chem 1998; 273:21542.</a></li><li><a class="nounderline abstract_t">Hoffman JF, Joiner W, Nehrke K, et al. The hSK4 (KCNN4) isoform is the Ca2+-activated K+ channel (Gardos channel) in human red blood cells. Proc Natl Acad Sci U S A 2003; 100:7366.</a></li><li><a class="nounderline abstract_t">Brugnara C, De Franceschi L, Alper SL. Ca(2+)-activated K+ transport in erythrocytes. Comparison of binding and transport inhibition by scorpion toxins. J Biol Chem 1993; 268:8760.</a></li><li><a class="nounderline abstract_t">Stocker JW, De Franceschi L, McNaughton-Smith GA, et al. ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice. Blood 2003; 101:2412.</a></li><li><a class="nounderline abstract_t">De Franceschi L, Saadane N, Trudel M, et al. Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease. J Clin Invest 1994; 93:1670.</a></li><li><a class="nounderline abstract_t">Brugnara C, Gee B, Armsby CC, et al. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. J Clin Invest 1996; 97:1227.</a></li><li><a class="nounderline abstract_t">Rapetti-Mauss R, Lacoste C, Picard V, et al. A mutation in the Gardos channel is associated with hereditary xerocytosis. Blood 2015; 126:1273.</a></li><li><a class="nounderline abstract_t">Glogowska E, Lezon-Geyda K, Maksimova Y, et al. Mutations in the Gardos channel (KCNN4) are associated with hereditary xerocytosis. Blood 2015; 126:1281.</a></li><li><a class="nounderline abstract_t">Andolfo I, Russo R, Manna F, et al. Novel Gardos channel mutations linked to dehydrated hereditary stomatocytosis (xerocytosis). Am J Hematol 2015; 90:921.</a></li><li><a class="nounderline abstract_t">Fermo E, Bogdanova A, Petkova-Kirova P, et al. 'Gardos Channelopathy': a variant of hereditary Stomatocytosis with complex molecular regulation. Sci Rep 2017; 7:1744.</a></li><li><a class="nounderline abstract_t">Allegrini B, Jedele S, David Nguyen L, et al. New KCNN4 Variants Associated With Anemia: Stomatocytosis Without Erythrocyte Dehydration. Front Physiol 2022; 13:918620.</a></li><li><a class="nounderline abstract_t">Ataga KI, Reid M, Ballas SK, et al. Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043). Br J Haematol 2011; 153:92.</a></li><li><a class="nounderline abstract_t">Rapetti-Mauss R, Soriani O, Vinti H, et al. Senicapoc: a potent candidate for the treatment of a subset of hereditary xerocytosis caused by mutations in the Gardos channel. Haematologica 2016; 101:e431.</a></li><li><a class="nounderline abstract_t">Rivera A, Vandorpe DH, Shmukler BE, et al. Erythrocytes from hereditary xerocytosis patients heterozygous for KCNN4 V282M exhibit increased spontaneous Gardos channel-like activity inhibited by senicapoc. Am J Hematol 2017; 92:E108.</a></li><li><a class="nounderline abstract_t">Bruce LJ, Guizouarn H, Burton NM, et al. The monovalent cation leak in overhydrated stomatocytic red blood cells results from amino acid substitutions in the Rh-associated glycoprotein. Blood 2009; 113:1350.</a></li><li><a class="nounderline abstract_t">Goossens D, Trinh-Trang-Tan MM, Debbia M, et al. Generation and characterisation of Rhd and Rhag null mice. Br J Haematol 2010; 148:161.</a></li><li><a class="nounderline abstract_t">Stewart AK, Shmukler BE, Vandorpe DH, et al. Loss-of-function and gain-of-function phenotypes of stomatocytosis mutant RhAG F65S. Am J Physiol Cell Physiol 2011; 301:C1325.</a></li><li><a class="nounderline abstract_t">Iolascon A, De Falco L, Borgese F, et al. A novel erythroid anion exchange variant (Gly796Arg) of hereditary stomatocytosis associated with dyserythropoiesis. Haematologica 2009; 94:1049.</a></li><li><a class="nounderline abstract_t">Chu H, Breite A, Ciraolo P, et al. Characterization of the deoxyhemoglobin binding site on human erythrocyte band 3: implications for O2 regulation of erythrocyte properties. Blood 2008; 111:932.</a></li><li><a class="nounderline abstract_t">Chu H, McKenna MM, Krump NA, et al. Reversible binding of hemoglobin to band 3 constitutes the molecular switch that mediates O2 regulation of erythrocyte properties. Blood 2016; 128:2708.</a></li><li><a class="nounderline abstract_t">Guizouarn H, Martial S, Gabillat N, Borgese F. Point mutations involved in red cell stomatocytosis convert the electroneutral anion exchanger 1 to a nonselective cation conductance. Blood 2007; 110:2158.</a></li><li><a class="nounderline abstract_t">Stewart AK, Kedar PS, Shmukler BE, et al. Functional characterization and modified rescue of novel AE1 mutation R730C associated with overhydrated cation leak stomatocytosis. Am J Physiol Cell Physiol 2011; 300:C1034.</a></li><li><a class="nounderline abstract_t">Bruce LJ, Robinson HC, Guizouarn H, et al. Monovalent cation leaks in human red cells caused by single amino-acid substitutions in the transport domain of the band 3 chloride-bicarbonate exchanger, AE1. Nat Genet 2005; 37:1258.</a></li><li><a class="nounderline abstract_t">Jarolim P, Rubin HL, Brabec V, et al. Mutations of conserved arginines in the membrane domain of erythroid band 3 lead to a decrease in membrane-associated band 3 and to the phenotype of hereditary spherocytosis. Blood 1995; 85:634.</a></li><li><a class="nounderline abstract_t">Paw BH, Davidson AJ, Zhou Y, et al. Cell-specific mitotic defect and dyserythropoiesis associated with erythroid band 3 deficiency. Nat Genet 2003; 34:59.</a></li><li><a class="nounderline abstract_t">Peters LL, Shivdasani RA, Liu SC, et al. Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton. Cell 1996; 86:917.</a></li><li><a class="nounderline abstract_t">Alper SL. Molecular physiology and genetics of Na+-independent SLC4 anion exchangers. J Exp Biol 2009; 212:1672.</a></li><li><a class="nounderline abstract_t">Ribeiro ML, Alloisio N, Almeida H, et al. Severe hereditary spherocytosis and distal renal tubular acidosis associated with the total absence of band 3. Blood 2000; 96:1602.</a></li><li><a class="nounderline abstract_t">Cordat E. Unraveling trafficking of the kidney anion exchanger 1 in polarized MDCK epithelial cells. Biochem Cell Biol 2006; 84:949.</a></li><li><a class="nounderline abstract_t">Kager L, Bruce LJ, Zeitlhofer P, et al. Band 3 nullVIENNA , a novel homozygous SLC4A1 p.Ser477X variant causing severe hemolytic anemia, dyserythropoiesis and complete distal renal tubular acidosis. Pediatr Blood Cancer 2017; 64.</a></li><li><a class="nounderline abstract_t">Perrotta S, Borriello A, Scaloni A, et al. The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function. Blood 2005; 106:4359.</a></li><li><a class="nounderline abstract_t">Stewart GW, Amess JA, Eber SW, et al. Thrombo-embolic disease after splenectomy for hereditary stomatocytosis. Br J Haematol 1996; 93:303.</a></li><li><a class="nounderline abstract_t">Andolfo I, Alper SL, Delaunay J, et al. Missense mutations in the ABCB6 transporter cause dominant familial pseudohyperkalemia. Am J Hematol 2013; 88:66.</a></li><li><a class="nounderline abstract_t">Andolfo I, Russo R, Manna F, et al. Functional characterization of novel ABCB6 mutations and their clinical implications in familial pseudohyperkalemia. Haematologica 2016; 101:909.</a></li><li><a class="nounderline abstract_t">Gallagher PG. Disorders of red cell volume regulation. Curr Opin Hematol 2013; 20:201.</a></li><li><a class="nounderline abstract_t">Badens C, Guizouarn H. Advances in understanding the pathogenesis of the red cell volume disorders. Br J Haematol 2016; 174:674.</a></li><li><a class="nounderline abstract_t">Shull GE, Schwartz A, Lingrel JB. Amino-acid sequence of the catalytic subunit of the (Na+ + K+)ATPase deduced from a complementary DNA. Nature 1985; 316:691.</a></li><li><a class="nounderline abstract_t">Martin-Vasallo P, Dackowski W, Emanuel JR, Levenson R. Identification of a putative isoform of the Na,K-ATPase beta subunit. Primary structure and tissue-specific expression. J Biol Chem 1989; 264:4613.</a></li><li><a class="nounderline abstract_t">Joiner CH, Lauf PK. Ouabain binding and potassium transport in young and old populations of human red cells. Membr Biochem 1978; 1:187.</a></li><li><a class="nounderline abstract_t">TOSTESON DC, HOFFMAN JF. Regulation of cell volume by active cation transport in high and low potassium sheep red cells. J Gen Physiol 1960; 44:169.</a></li><li><a class="nounderline abstract_t">Strehler EE, James P, Fischer R, et al. Peptide sequence analysis and molecular cloning reveal two calcium pump isoforms in the human erythrocyte membrane. J Biol Chem 1990; 265:2835.</a></li><li><a class="nounderline abstract_t">Lew VL, Daw N, Perdomo D, et al. Distribution of plasma membrane Ca2+ pump activity in normal human red blood cells. Blood 2003; 102:4206.</a></li><li><a class="nounderline abstract_t">Lew VL, Daw N, Etzion Z, et al. Effects of age-dependent membrane transport changes on the homeostasis of senescent human red blood cells. Blood 2007; 110:1334.</a></li><li><a class="nounderline abstract_t">Féray JC, Garay R. An Na+-stimulated Mg2+-transport system in human red blood cells. Biochim Biophys Acta 1986; 856:76.</a></li><li><a class="nounderline abstract_t">Kolisek M, Nestler A, Vormann J, Schweigel-Röntgen M. Human gene SLC41A1 encodes for the Na+/Mg²+ exchanger. Am J Physiol Cell Physiol 2012; 302:C318.</a></li><li><a class="nounderline abstract_t">Morgan K, Canessa M. Interactions of external and internal H+ and Na+ with Na+/Na+ and Na+/H+ exchange of rabbit red cells: evidence for a common pathway. J Membr Biol 1990; 118:193.</a></li><li><a class="nounderline abstract_t">De Franceschi L, Rivera A, Bize I, et al. Murine Spherocytosis: Evidence for a Functional Interaction between Protein 4.1 and Na/H Exchange and for a "Protective" Role of the Gardos Channel Against Hemolysis (abstract). Blood 2004; 104:578a.</a></li><li><a class="nounderline abstract_t">Nunomura W, Denker SP, Barber DL, et al. Characterization of cytoskeletal protein 4.1R interaction with NHE1 (Na(+)/H(+) exchanger isoform 1). Biochem J 2012; 446:427.</a></li><li><a class="nounderline abstract_t">Foller M, Kasinathan RS, Koka S, et al. TRPC6 contributes to the Ca(2+) leak of human erythrocytes. Cell Physiol Biochem 2008; 21:183.</a></li><li><a class="nounderline abstract_t">Qadri SM, Bissinger R, Solh Z, Oldenborg PA. Eryptosis in health and disease: A paradigm shift towards understanding the (patho)physiological implications of programmed cell death of erythrocytes. Blood Rev 2017; 31:349.</a></li><li><a class="nounderline abstract_t">Wiley JS, Cooper RA. A furosemide-sensitive cotransport of sodium plus potassium in the human red cell. J Clin Invest 1974; 53:745.</a></li><li><a class="nounderline abstract_t">Brugnara C, Canessa M, Cusi D, Tosteson DC. Furosemide-sensitive Na and K fluxes in human red cells. Net uphill Na extrusion and equilibrium properties. J Gen Physiol 1986; 87:91.</a></li><li><a class="nounderline abstract_t">Gillen CM, Brill S, Payne JA, Forbush B 3rd. Molecular cloning and functional expression of the K-Cl cotransporter from rabbit, rat, and human. A new member of the cation-chloride cotransporter family. J Biol Chem 1996; 271:16237.</a></li><li><a class="nounderline abstract_t">Payne JA, Stevenson TJ, Donaldson LF. Molecular characterization of a putative K-Cl cotransporter in rat brain. A neuronal-specific isoform. J Biol Chem 1996; 271:16245.</a></li><li><a class="nounderline abstract_t">Race JE, Makhlouf FN, Logue PJ, et al. Molecular cloning and functional characterization of KCC3, a new K-Cl cotransporter. Am J Physiol 1999; 277:C1210.</a></li><li><a class="nounderline abstract_t">Mercado A, Song L, Vazquez N, et al. Functional comparison of the K+-Cl- cotransporters KCC1 and KCC4. J Biol Chem 2000; 275:30326.</a></li><li><a class="nounderline abstract_t">Brugnara C, Kopin AS, Bunn HF, Tosteson DC. Regulation of cation content and cell volume in hemoglobin erythrocytes from patients with homozygous hemoglobin C disease. J Clin Invest 1985; 75:1608.</a></li><li><a class="nounderline abstract_t">Brugnara C, Bunn HF, Tosteson DC. Regulation of erythrocyte cation and water content in sickle cell anemia. Science 1986; 232:388.</a></li><li><a class="nounderline abstract_t">De Franceschi L, Ronzoni L, Cappellini MD, et al. K-CL co-transport plays an important role in normal and beta thalassemic erythropoiesis. Haematologica 2007; 92:1319.</a></li><li><a class="nounderline abstract_t">De Franceschi L, Cappellini MD, Graziadei G, et al. The effect of dietary magnesium supplementation on the cellular abnormalities of erythrocytes in patients with beta thalassemia intermedia. Haematologica 1998; 83:118.</a></li><li><a class="nounderline abstract_t">Brugnara C, Tosteson DC. Cell volume, K transport, and cell density in human erythrocytes. Am J Physiol 1987; 252:C269.</a></li><li><a class="nounderline abstract_t">Godart H, Ellory JC. KCl cotransport activation in human erythrocytes by high hydrostatic pressure. J Physiol 1996; 491 ( Pt 2):423.</a></li><li><a class="nounderline abstract_t">Kaji DM, Gasson C. Urea activation of K-Cl transport in human erythrocytes. Am J Physiol 1995; 268:C1018.</a></li><li><a class="nounderline abstract_t">Olivieri O, Bonollo M, Friso S, et al. Activation of K+/Cl- cotransport in human erythrocytes exposed to oxidative agents. Biochim Biophys Acta 1993; 1176:37.</a></li><li><a class="nounderline abstract_t">Joiner CH, Rettig RK, Jiang M, et al. Urea stimulation of KCl cotransport induces abnormal volume reduction in sickle reticulocytes. Blood 2007; 109:1728.</a></li><li><a class="nounderline abstract_t">Olivieri O, Vitoux D, Galacteros F, et al. Hemoglobin variants and activity of the (K+Cl-) cotransport system in human erythrocytes. Blood 1992; 79:793.</a></li><li><a class="nounderline abstract_t">Nagel RL, Krishnamoorthy R, Fattoum S, et al. The erythrocyte effects of haemoglobin O(ARAB). Br J Haematol 1999; 107:516.</a></li><li><a class="nounderline abstract_t">Romero JR, Suzuka SM, Nagel RL, Fabry ME. Expression of HbC and HbS, but not HbA, results in activation of K-Cl cotransport activity in transgenic mouse red cells. Blood 2004; 103:2384.</a></li><li><a class="nounderline abstract_t">Brugnara C, Tosteson DC. Inhibition of K transport by divalent cations in sickle erythrocytes. Blood 1987; 70:1810.</a></li><li><a class="nounderline abstract_t">Agre P, King LS, Yasui M, et al. Aquaporin water channels--from atomic structure to clinical medicine. J Physiol 2002; 542:3.</a></li><li><a class="nounderline abstract_t">Preston GM, Carroll TP, Guggino WB, Agre P. Appearance of water channels in Xenopus oocytes expressing red cell CHIP28 protein. Science 1992; 256:385.</a></li><li><a class="nounderline abstract_t">Smith BL, Preston GM, Spring FA, et al. Human red cell aquaporin CHIP. I. Molecular characterization of ABH and Colton blood group antigens. J Clin Invest 1994; 94:1043.</a></li><li><a class="nounderline abstract_t">Preston GM, Smith BL, Zeidel ML, et al. Mutations in aquaporin-1 in phenotypically normal humans without functional CHIP water channels. Science 1994; 265:1585.</a></li><li><a class="nounderline abstract_t">King LS, Choi M, Fernandez PC, et al. Defective urinary concentrating ability due to a complete deficiency of aquaporin-1. N Engl J Med 2001; 345:175.</a></li><li><a class="nounderline abstract_t">Bookchin RM, Etzion Z, Sorette M, et al. Identification and characterization of a newly recognized population of high-Na+, low-K+, low-density sickle and normal red cells. Proc Natl Acad Sci U S A 2000; 97:8045.</a></li><li><a class="nounderline abstract_t">Holtzclaw JD, Jiang M, Yasin Z, et al. Rehydration of high-density sickle erythrocytes in vitro. Blood 2002; 100:3017.</a></li><li><a class="nounderline abstract_t">Sheetz MP, Singer SJ. Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. Proc Natl Acad Sci U S A 1974; 71:4457.</a></li><li><a class="nounderline abstract_t">Deuticke B. Transformation and restoration of biconcave shape of human erythrocytes induced by amphiphilic agents and changes of ionic environment. Biochim Biophys Acta 1968; 163:494.</a></li><li><a class="nounderline abstract_t">Kanzaki A, Yawata Y. Hereditary stomatocytosis: phenotypical expression of sodium transport and band 7 peptides in 44 cases. Br J Haematol 1992; 82:133.</a></li><li><a class="nounderline abstract_t">Rinehart J, Gulcicek EE, Joiner CH, et al. Determinants of erythrocyte hydration. Curr Opin Hematol 2010; 17:191.</a></li><li><a class="nounderline abstract_t">Vives Corrons JL, Besson I, Aymerich M, et al. Hereditary xerocytosis: a report of six unrelated Spanish families with leaky red cell syndrome and increased heat stability of the erythrocyte membrane. Br J Haematol 1995; 90:817.</a></li><li><a class="nounderline abstract_t">Paterakis GS, Laoutaris NP, Alexia SV, et al. The effect of red cell shape on the measurement of red cell volume. A proposed method for the comparative assessment of this effect among various haematology analysers. Clin Lab Haematol 1994; 16:235.</a></li><li><a class="nounderline abstract_t">Shojania AM, Godin DV, Frohlich J. Hereditary high phosphatidylcholine hemolytic anemia: report of a new family and review of the literature. Clin Invest Med 1990; 13:313.</a></li><li><a class="nounderline abstract_t">Yoshimoto A, Fujimura M, Nakao S. Pulmonary hypertension after splenectomy in hereditary stomatocytosis. Am J Med Sci 2005; 330:195.</a></li><li><a class="nounderline abstract_t">Vicente-Gutiérrez MP, Castelló-Almazán I, Salvía-Roiges MD, et al. Nonimmune hydrops fetalis due to congenital xerocytosis. J Perinatol 2005; 25:63.</a></li><li><a class="nounderline abstract_t">Ogburn PL Jr, Ramin KD, Danilenko-Dixon D, et al. In utero erythrocyte transfusion for fetal xerocytosis associated with severe anemia and non-immune hydrops fetalis. Am J Obstet Gynecol 2001; 185:238.</a></li><li class="breakAll">Gallagher PG, Forget BG, Lux SE. Disorders of the erythrocyte membrane. In: Hematology of Infancy and Childhood, Nathan DG, Orkin SH, Ginsburg D, Look TA (Eds), WB Saunders, Philadelphia 2003. p.560.</li><li><a class="nounderline abstract_t">Platt OS, Lux SE, Nathan DG. Exercise-induced hemolysis in xerocytosis. Erythrocyte dehydration and shear sensitivity. J Clin Invest 1981; 68:631.</a></li><li><a class="nounderline abstract_t">Wiley JS, Cooper RA, Adachi K, Asakura T. Hereditary stomatocytosis: association of low 2,3-diphosphoglycerate with increased cation pumping by the red cell. Br J Haematol 1979; 41:133.</a></li><li><a class="nounderline abstract_t">Darghouth D, Koehl B, Heilier JF, et al. Alterations of red blood cell metabolome in overhydrated hereditary stomatocytosis. Haematologica 2011; 96:1861.</a></li><li><a class="nounderline abstract_t">Smith BD, Segel GB. Abnormal erythrocyte endothelial adherence in hereditary stomatocytosis. Blood 1997; 89:3451.</a></li><li><a class="nounderline abstract_t">Eber SW, Lande WM, Iarocci TA, et al. Hereditary stomatocytosis: consistent association with an integral membrane protein deficiency. Br J Haematol 1989; 72:452.</a></li><li><a class="nounderline abstract_t">Fricke B, Argent AC, Chetty MC, et al. The "stomatin" gene and protein in overhydrated hereditary stomatocytosis. Blood 2003; 102:2268.</a></li><li><a class="nounderline abstract_t">Lande WM, Thiemann PV, Mentzer WC Jr. Missing band 7 membrane protein in two patients with high Na, low K erythrocytes. J Clin Invest 1982; 70:1273.</a></li><li><a class="nounderline abstract_t">Jaffé ER, Gottfried EL. Hereditary nonspherocytic hemolytic disease associated with an altered phospholipid composition of the erythrocytes. J Clin Invest 1968; 47:1375.</a></li><li><a class="nounderline abstract_t">Wiley JS, Ellory JC, Shuman MA, et al. Characteristics of the membrane defect in the hereditary stomatocytosis syndrome. Blood 1975; 46:337.</a></li><li><a class="nounderline abstract_t">Shohet SB, Nathan DG, Livermore BM, et al. Hereditary hemolytic anemia associated with abnormal membrane lipid. II. Ion permeability and transport abnormalities. Blood 1973; 42:1.</a></li><li><a class="nounderline abstract_t">Kaufman HW, Niles JK, Gallagher DR, et al. Revised prevalence estimate of possible Hereditary Xerocytosis as derived from a large U.S. Laboratory database. Am J Hematol 2018; 93:E9.</a></li><li><a class="nounderline abstract_t">Entezami M, Becker R, Menssen HD, et al. Xerocytosis with concomitant intrauterine ascites: first description and therapeutic approach. Blood 1996; 87:5392.</a></li><li><a class="nounderline abstract_t">Grootenboer-Mignot S, Crétien A, Laurendeau I, et al. Sub-lethal hydrops as a manifestation of dehydrated hereditary stomatocytosis in two consecutive pregnancies. Prenat Diagn 2003; 23:380.</a></li><li><a class="nounderline abstract_t">Grootenboer S, Schischmanoff PO, Laurendeau I, et al. Pleiotropic syndrome of dehydrated hereditary stomatocytosis, pseudohyperkalemia, and perinatal edema maps to 16q23-q24. Blood 2000; 96:2599.</a></li><li><a class="nounderline abstract_t">Jamwal M, Singh N, Sharma P, et al. Dehydrated hereditary stomatocytosis masquerading as primary haemochromatosis: a diagnostic challenge. Pathology 2023; 55:876.</a></li><li><a class="nounderline abstract_t">Imashuku S, Suemori SI, Wakamatsu M, et al. Juvenile Hemochromatosis With Non-transfused Hemolytic Anemia Caused by a De Novo PIEZO1 Gene Mutation. J Pediatr Hematol Oncol 2023; 45:e510.</a></li><li><a class="nounderline abstract_t">Picard V, Guitton C, Thuret I, et al. Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients. Haematologica 2019; 104:1554.</a></li><li><a class="nounderline abstract_t">Wiley JS. Inherited red cell dehydration: a hemolytic syndrome in search of a name. Pathology 1984; 16:115.</a></li><li><a class="nounderline abstract_t">Jenner B, Brockelsby J, Thomas W. Dehydrated hereditary stomatocytosis causing fetal hydrops and perinatal ascites. Br J Haematol 2018; 182:620.</a></li><li><a class="nounderline abstract_t">Sparks TN, Lianoglou BR, Adami RR, et al. Exome Sequencing for Prenatal Diagnosis in Nonimmune Hydrops Fetalis. N Engl J Med 2020; 383:1746.</a></li><li><a class="nounderline abstract_t">Mansour-Hendili L, Egée S, Monedero-Alonso D, et al. Multiple thrombosis in a patient with Gardos channelopathy and a new KCNN4 mutation. Am J Hematol 2021; 96:E318.</a></li><li><a class="nounderline abstract_t">Stewart GW, Corrall RJ, Fyffe JA, et al. Familial pseudohyperkalaemia. A new syndrome. Lancet 1979; 2:175.</a></li><li><a class="nounderline abstract_t">Alani FS, Dyer T, Hindle E, et al. Pseudohyperkalaemia associated with hereditary spherocytosis in four members of a family. Postgrad Med J 1994; 70:749.</a></li><li><a class="nounderline abstract_t">Fricke B, Jarvis HG, Reid CD, et al. Four new cases of stomatin-deficient hereditary stomatocytosis syndrome: association of the stomatin-deficient cryohydrocytosis variant with neurological dysfunction. Br J Haematol 2004; 125:796.</a></li><li><a class="nounderline abstract_t">Russo R, Marra R, Rosato BE, et al. Genetics and Genomics Approaches for Diagnosis and Research Into Hereditary Anemias. Front Physiol 2020; 11:613559.</a></li><li class="breakAll">Gallagher PG, Lux SE. Disorders of the erythrocyte membrane. In: Hematology of Infancy and Childhood, Nathan DG, Orkin SH, Ginsburg D, Look TA (Eds), WB Saunders, Philadelphia 2003. p.560.</li><li><a class="nounderline abstract_t">Jarvis HG, Gore DM, Briggs C, et al. Cold storage of 'cryohydrocytosis' red cells: the osmotic susceptibility of the cold-stored erythrocyte. Br J Haematol 2003; 122:859.</a></li><li><a class="nounderline abstract_t">Andolfo I, Russo R, Gambale A, Iolascon A. New insights on hereditary erythrocyte membrane defects. Haematologica 2016; 101:1284.</a></li><li><a class="nounderline abstract_t">Bogdanova A, Goede JS, Weiss E, et al. Cryohydrocytosis: increased activity of cation carriers in red cells from a patient with a band 3 mutation. Haematologica 2010; 95:189.</a></li><li><a class="nounderline abstract_t">LOCK SP, SMITH RS, HARDISTY RM. Stomatocytosis: a hereditary red cell anomally associated with haemolytic anaemia. Br J Haematol 1961; 7:303.</a></li><li><a class="nounderline abstract_t">Andolfo I, Manna F, De Rosa G, et al. PIEZO1-R1864H rare variant accounts for a genetic phenotype-modifier role in dehydrated hereditary stomatocytosis. Haematologica 2018; 103:e94.</a></li><li><a class="nounderline abstract_t">Kiger L, Oliveira L, Guitton C, et al. Piezo1-xerocytosis red cell metabolome shows impaired glycolysis and increased hemoglobin oxygen affinity. Blood Adv 2021; 5:84.</a></li><li><a class="nounderline abstract_t">Ballas SK, Clark MR, Mohandas N, et al. Red cell membrane and cation deficiency in Rh null syndrome. Blood 1984; 63:1046.</a></li><li><a class="nounderline abstract_t">Remaley AT, Schumacher UK, Stonik JA, et al. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler Thromb Vasc Biol 1997; 17:1813.</a></li><li><a class="nounderline abstract_t">Reinhart WH, Gössi U, Bütikofer P, et al. Haemolytic anaemia in analpha-lipoproteinaemia (Tangier disease): morphological, biochemical, and biophysical properties of the red blood cell. Br J Haematol 1989; 72:272.</a></li><li><a class="nounderline abstract_t">Neff AT. Sitosterolemia's stomatocytosis and macrothrombocytopenia. Blood 2012; 120:4283.</a></li><li><a class="nounderline abstract_t">Wang Z, Cao L, Su Y, et al. Specific macrothrombocytopenia/hemolytic anemia associated with sitosterolemia. Am J Hematol 2014; 89:320.</a></li><li><a class="nounderline abstract_t">Goodyer M, Lovey J, Menétrey MJ. Peripheral blood features of phytosterolaemia. Br J Haematol 2015; 171:669.</a></li><li><a class="nounderline abstract_t">Wislöff F, Boman D. Acquired stomatocytosis in alcoholic liver disease. Scand J Haematol 1979; 23:43.</a></li><li><a class="nounderline abstract_t">Douglass CC, Twomey JJ. Transient stomatocytosis with hemolysis: a previously unrecognized complication of alcoholism. Ann Intern Med 1970; 72:159.</a></li><li><a class="nounderline abstract_t">Ohsaka A, Kano Y, Sakamoto S, et al. A transient hemolytic reaction and stomatocytosis following vinca alkaloid administration. Nihon Ketsueki Gakkai Zasshi 1989; 52:7.</a></li><li><a class="nounderline abstract_t">Schrier SL, Zachowski A, Devaux PF. Mechanisms of amphipath-induced stomatocytosis in human erythrocytes. Blood 1992; 79:782.</a></li><li><a class="nounderline abstract_t">Clark MR, Morrison CE, Shohet SB. Monovalent cation transport in irreversibly sickled cells. J Clin Invest 1978; 62:329.</a></li><li><a class="nounderline abstract_t">Bertles JF, Milner PF. Irreversibly sickled erythrocytes: a consequence of the heterogeneous distribution of hemoglobin types in sickle-cell anemia. J Clin Invest 1968; 47:1731.</a></li><li><a class="nounderline abstract_t">Gibson JS, Speake PF, Ellory JC. Differential oxygen sensitivity of the K+-Cl- cotransporter in normal and sickle human red blood cells. J Physiol 1998; 511 ( Pt 1):225.</a></li><li><a class="nounderline abstract_t">Brugnara C, de Franceschi L, Alper SL. Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J Clin Invest 1993; 92:520.</a></li><li><a class="nounderline abstract_t">Kaul DK, Chen D, Zhan J. Adhesion of sickle cells to vascular endothelium is critically dependent on changes in density and shape of the cells. Blood 1994; 83:3006.</a></li><li><a class="nounderline abstract_t">Kaul DK, Fabry ME, Nagel RL. Vaso-occlusion by sickle cells: evidence for selective trapping of dense red cells. Blood 1986; 68:1162.</a></li><li><a class="nounderline abstract_t">Ballas SK, Smith ED. Red blood cell changes during the evolution of the sickle cell painful crisis. Blood 1992; 79:2154.</a></li><li><a class="nounderline abstract_t">Lawrence C, Fabry ME, Nagel RL. Red cell distribution width parallels dense red cell disappearance during painful crises in sickle cell anemia. J Lab Clin Med 1985; 105:706.</a></li><li><a class="nounderline abstract_t">Brugnara C. Characteristics of the volume- and chloride-dependent K transport in human erythrocytes homozygous for hemoglobin C. J Membr Biol 1989; 111:69.</a></li><li><a class="nounderline abstract_t">Fabry ME, Romero JR, Suzuka SM, et al. Hemoglobin C in transgenic mice with full mouse globin knockouts [abstract]. Blood 1998; 92:330a.</a></li><li><a class="nounderline abstract_t">El Nabouch M, Rakotoharinandrasana I, Ndayikeza A, et al. Infantile pyknocytosis, a rare cause of hemolytic anemia in newborns: report of two cases in twin girls and literature overview. Clin Case Rep 2015; 3:535.</a></li><li><a class="nounderline abstract_t">Coutinho M, Costa E, Monteiro T, et al. Infantile pyknocytosis: an under-recognized form of neonatal hemolytic anemia? Lab Hematol 2012; 18:27.</a></li><li><a class="nounderline abstract_t">Eyssette-Guerreau S, Bader-Meunier B, Garcon L, et al. Infantile pyknocytosis: a cause of haemolytic anaemia of the newborn. Br J Haematol 2006; 133:439.</a></li></ol></div><div id="topicVersionRevision">Topic 7068 Version 59.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28971506" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Hereditary stomatocytosis: An underdiagnosed condition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8416292" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Hereditary hemolytic disease with increased red blood cell phosphatidylcholine and dehydration: one, two, or many disorders?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8043931" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The membrane defect in hereditary stomatocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19644134" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The hereditary stomatocytoses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25790109" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30187933" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Genotype-phenotype correlation and risk stratification in a cohort of 123 hereditary stomatocytosis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30237269" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : A novel gain-of-function mutation of Piezo1 is functionally affirmed in red blood cells by high-throughput patch clamp.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22492876" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : An infant with pseudohyperkalemia, hemolysis, and seizures: cation-leaky GLUT1-deficiency syndrome due to a SLC2A1 mutation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21791420" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Stomatin-deficient cryohydrocytosis results from mutations in SLC2A1: a novel form of GLUT1 deficiency syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16029460" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Stomatocytic haemolysis and macrothrombocytopenia (Mediterranean stomatocytosis/macrothrombocytopenia) is the haematological presentation of phytosterolaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24623560" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : A novel mutation of ABCG5 gene in a Turkish boy with phytosterolemia presenting with macrotrombocytopenia and stomatocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22297561" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Macrothrombocytopenia/stomatocytosis specially associated with phytosterolemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23487776" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Xerocytosis is caused by mutations that alter the kinetics of the mechanosensitive channel PIEZO1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23872304" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Piezo1 plays a role in erythrocyte volume homeostasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25044010" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Hereditary xerocytosis revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22529292" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Mutations in the mechanotransduction protein PIEZO1 are associated with hereditary xerocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23479567" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23695678" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Dehydrated hereditary stomatocytosis linked to gain-of-function mutations in mechanically activated PIEZO1 ion channels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28716860" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Novel mechanisms of PIEZO1 dysfunction in hereditary xerocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26440377" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Dehydrated hereditary stomatocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36864026" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Variant spectrum of PIEZO1 and KCNN4 in Japanese patients with dehydrated hereditary stomatocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33973227" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Characterisation of Asp669Tyr Piezo1 cation channel activity in red blood cells: an unexpected phenotype.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31413092" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : PIEZO1 activation delays erythroid differentiation of normal and hereditary xerocytosis-derived human progenitor cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31624108" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : PIEZO1 gain-of-function mutations delay reticulocyte maturation in hereditary xerocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28367341" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Hereditary Xerocytosis due to Mutations in PIEZO1 Gene Associated with Heterozygous Pyruvate Kinase Deficiency and Beta-Thalassemia Trait in Two Unrelated Families.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34201899" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Complex Modes of Inheritance in Hereditary Red Blood Cell Disorders: A Case Series Study of 155 Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28121068" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Hemoglobin C trait accentuates erythrocyte dehydration in hereditary xerocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36882369" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Coinheritance of PIEZO1 variants and multi-locus red blood cell defects account for the symptomatic phenotype in beta-thalassemia carriers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29576450" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Common PIEZO1 Allele in African Populations Causes RBC Dehydration and Attenuates Plasmodium Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28552477" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Genome-wide association study of erythrocyte density in sickle cell disease patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36122374" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Missense mutations in PIEZO1, which encodes the Piezo1 mechanosensor protein, define Er red blood cell antigens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13618284" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The function of calcium in the potassium permeability of human erythrocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9326665" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : A human intermediate conductance calcium-activated potassium channel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9705284" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : cDNA cloning and functional characterization of the mouse Ca2+-gated K+ channel, mIK1. Roles in regulatory volume decrease and erythroid differentiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12773623" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The hSK4 (KCNN4) isoform is the Ca2+-activated K+ channel (Gardos channel) in human red blood cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7682555" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Ca(2+)-activated K+ transport in erythrocytes. Comparison of binding and transport inhibition by scorpion toxins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12433690" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7512989" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8636434" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26148990" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : A mutation in the Gardos channel is associated with hereditary xerocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26198474" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Mutations in the Gardos channel (KCNN4) are associated with hereditary xerocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26178367" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Novel Gardos channel mutations linked to dehydrated hereditary stomatocytosis (xerocytosis).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28496185" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : 'Gardos Channelopathy': a variant of hereditary Stomatocytosis with complex molecular regulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36003639" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : New KCNN4 Variants Associated With Anemia: Stomatocytosis Without Erythrocyte Dehydration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21323872" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27443288" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Senicapoc: a potent candidate for the treatment of a subset of hereditary xerocytosis caused by mutations in the Gardos channel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28295477" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Erythrocytes from hereditary xerocytosis patients heterozygous for KCNN4 V282M exhibit increased spontaneous Gardos channel-like activity inhibited by senicapoc.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18931342" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : The monovalent cation leak in overhydrated stomatocytic red blood cells results from amino acid substitutions in the Rh-associated glycoprotein.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19807729" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Generation and characterisation of Rhd and Rhag null mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21849667" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Loss-of-function and gain-of-function phenotypes of stomatocytosis mutant RhAG F65S.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19644137" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : A novel erythroid anion exchange variant (Gly796Arg) of hereditary stomatocytosis associated with dyserythropoiesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17942752" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Characterization of the deoxyhemoglobin binding site on human erythrocyte band 3: implications for O2 regulation of erythrocyte properties.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27688804" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Reversible binding of hemoglobin to band 3 constitutes the molecular switch that mediates O2 regulation of erythrocyte properties.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17554061" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Point mutations involved in red cell stomatocytosis convert the electroneutral anion exchanger 1 to a nonselective cation conductance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21209359" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Functional characterization and modified rescue of novel AE1 mutation R730C associated with overhydrated cation leak stomatocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16227998" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Monovalent cation leaks in human red cells caused by single amino-acid substitutions in the transport domain of the band 3 chloride-bicarbonate exchanger, AE1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7530501" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Mutations of conserved arginines in the membrane domain of erythroid band 3 lead to a decrease in membrane-associated band 3 and to the phenotype of hereditary spherocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12669066" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Cell-specific mitotic defect and dyserythropoiesis associated with erythroid band 3 deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8808627" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19448077" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Molecular physiology and genetics of Na+-independent SLC4 anion exchangers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10942416" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Severe hereditary spherocytosis and distal renal tubular acidosis associated with the total absence of band 3.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17215882" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Unraveling trafficking of the kidney anion exchanger 1 in polarized MDCK epithelial cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27718309" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Band 3 nullVIENNA , a novel homozygous SLC4A1 p.Ser477X variant causing severe hemolytic anemia, dyserythropoiesis and complete distal renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16118313" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8639421" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Thrombo-embolic disease after splenectomy for hereditary stomatocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23180570" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Missense mutations in the ABCB6 transporter cause dominant familial pseudohyperkalemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27151991" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Functional characterization of novel ABCB6 mutations and their clinical implications in familial pseudohyperkalemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23519154" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Disorders of red cell volume regulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27353637" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Advances in understanding the pathogenesis of the red cell volume disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2993903" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Amino-acid sequence of the catalytic subunit of the (Na+ + K+)ATPase deduced from a complementary DNA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2538450" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Identification of a putative isoform of the Na,K-ATPase beta subunit. Primary structure and tissue-specific expression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/756487" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Ouabain binding and potassium transport in young and old populations of human red cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13777653" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Regulation of cell volume by active cation transport in high and low potassium sheep red cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2137451" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Peptide sequence analysis and molecular cloning reveal two calcium pump isoforms in the human erythrocyte membrane.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12920020" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Distribution of plasma membrane Ca2+ pump activity in normal human red blood cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17456724" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Effects of age-dependent membrane transport changes on the homeostasis of senescent human red blood cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3955035" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : An Na+-stimulated Mg2+-transport system in human red blood cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22031603" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Human gene SLC41A1 encodes for the Na+/Mg²+ exchanger.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1963903" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Interactions of external and internal H+ and Na+ with Na+/Na+ and Na+/H+ exchange of rabbit red cells: evidence for a common pathway.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Murine Spherocytosis: Evidence for a Functional Interaction between Protein 4.1 and Na/H Exchange and for a "Protective" Role of the Gardos Channel Against Hemolysis (abstract)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22731252" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Characterization of cytoskeletal protein 4.1R interaction with NHE1 (Na(+)/H(+) exchanger isoform 1).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18209485" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : TRPC6 contributes to the Ca(2+) leak of human erythrocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28669393" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Eryptosis in health and disease: A paradigm shift towards understanding the (patho)physiological implications of programmed cell death of erythrocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4812437" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : A furosemide-sensitive cotransport of sodium plus potassium in the human red cell.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3950577" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Furosemide-sensitive Na and K fluxes in human red cells. Net uphill Na extrusion and equilibrium properties.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8663127" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Molecular cloning and functional expression of the K-Cl cotransporter from rabbit, rat, and human. A new member of the cation-chloride cotransporter family.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8663311" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Molecular characterization of a putative K-Cl cotransporter in rat brain. A neuronal-specific isoform.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10600773" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Molecular cloning and functional characterization of KCC3, a new K-Cl cotransporter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10913127" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Functional comparison of the K+-Cl- cotransporters KCC1 and KCC4.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3998150" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Regulation of cation content and cell volume in hemoglobin erythrocytes from patients with homozygous hemoglobin C disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3961486" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Regulation of erythrocyte cation and water content in sickle cell anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18024369" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : K-CL co-transport plays an important role in normal and beta thalassemic erythropoiesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9549922" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : The effect of dietary magnesium supplementation on the cellular abnormalities of erythrocytes in patients with beta thalassemia intermedia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3826356" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Cell volume, K transport, and cell density in human erythrocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8866865" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : KCl cotransport activation in human erythrocytes by high hydrostatic pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7733222" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Urea activation of K-Cl transport in human erythrocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8452877" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Activation of K+/Cl- cotransport in human erythrocytes exposed to oxidative agents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17023583" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Urea stimulation of KCl cotransport induces abnormal volume reduction in sickle reticulocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1732017" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Hemoglobin variants and activity of the (K+Cl-) cotransport system in human erythrocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10583251" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : The erythrocyte effects of haemoglobin O(ARAB).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14615383" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Expression of HbC and HbS, but not HbA, results in activation of K-Cl cotransport activity in transgenic mouse red cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3676515" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Inhibition of K transport by divalent cations in sickle erythrocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12096044" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Aquaporin water channels--from atomic structure to clinical medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1373524" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Appearance of water channels in Xenopus oocytes expressing red cell CHIP28 protein.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7521882" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Human red cell aquaporin CHIP. I. Molecular characterization of ABH and Colton blood group antigens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7521540" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Mutations in aquaporin-1 in phenotypically normal humans without functional CHIP water channels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11463012" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Defective urinary concentrating ability due to a complete deficiency of aquaporin-1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10859357" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Identification and characterization of a newly recognized population of high-Na+, low-K+, low-density sickle and normal red cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12351416" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Rehydration of high-density sickle erythrocytes in vitro.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4530994" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4387277" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Transformation and restoration of biconcave shape of human erythrocytes induced by amphiphilic agents and changes of ionic environment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1419788" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Hereditary stomatocytosis: phenotypical expression of sodium transport and band 7 peptides in 44 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20182354" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Determinants of erythrocyte hydration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7669659" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Hereditary xerocytosis: a report of six unrelated Spanish families with leaky red cell syndrome and increased heat stability of the erythrocyte membrane.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7828411" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : The effect of red cell shape on the measurement of red cell volume. A proposed method for the comparative assessment of this effect among various haematology analysers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1964113" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Hereditary high phosphatidylcholine hemolytic anemia: report of a new family and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16234613" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Pulmonary hypertension after splenectomy in hereditary stomatocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15608620" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Nonimmune hydrops fetalis due to congenital xerocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11483935" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : In utero erythrocyte transfusion for fetal xerocytosis associated with severe anemia and non-immune hydrops fetalis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11483935" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : In utero erythrocyte transfusion for fetal xerocytosis associated with severe anemia and non-immune hydrops fetalis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7276163" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Exercise-induced hemolysis in xerocytosis. Erythrocyte dehydration and shear sensitivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/420735" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Hereditary stomatocytosis: association of low 2,3-diphosphoglycerate with increased cation pumping by the red cell.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21859730" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Alterations of red blood cell metabolome in overhydrated hereditary stomatocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9129053" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Abnormal erythrocyte endothelial adherence in hereditary stomatocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2765409" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Hereditary stomatocytosis: consistent association with an integral membrane protein deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12750157" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : The "stomatin" gene and protein in overhydrated hereditary stomatocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7174793" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Missing band 7 membrane protein in two patients with high Na, low K erythrocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5653215" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Hereditary nonspherocytic hemolytic disease associated with an altered phospholipid composition of the erythrocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1148392" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Characteristics of the membrane defect in the hereditary stomatocytosis syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4717407" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Hereditary hemolytic anemia associated with abnormal membrane lipid. II. Ion permeability and transport abnormalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28971500" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Revised prevalence estimate of possible Hereditary Xerocytosis as derived from a large U.S. Laboratory database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8652859" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Xerocytosis with concomitant intrauterine ascites: first description and therapeutic approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12749034" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Sub-lethal hydrops as a manifestation of dehydrated hereditary stomatocytosis in two consecutive pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11001917" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Pleiotropic syndrome of dehydrated hereditary stomatocytosis, pseudohyperkalemia, and perinatal edema maps to 16q23-q24.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37393146" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Dehydrated hereditary stomatocytosis masquerading as primary haemochromatosis: a diagnostic challenge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36898020" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Juvenile Hemochromatosis With Non-transfused Hemolytic Anemia Caused by a De Novo PIEZO1 Gene Mutation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30655378" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6462773" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Inherited red cell dehydration: a hemolytic syndrome in search of a name.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29767406" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Dehydrated hereditary stomatocytosis causing fetal hydrops and perinatal ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33027564" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Exome Sequencing for Prenatal Diagnosis in Nonimmune Hydrops Fetalis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34004026" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Multiple thrombosis in a patient with Gardos channelopathy and a new KCNN4 mutation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/89283" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Familial pseudohyperkalaemia. A new syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7831176" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Pseudohyperkalaemia associated with hereditary spherocytosis in four members of a family.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15180870" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Four new cases of stomatin-deficient hereditary stomatocytosis syndrome: association of the stomatin-deficient cryohydrocytosis variant with neurological dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33414725" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Genetics and Genomics Approaches for Diagnosis and Research Into Hereditary Anemias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33414725" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Genetics and Genomics Approaches for Diagnosis and Research Into Hereditary Anemias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12930402" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Cold storage of 'cryohydrocytosis' red cells: the osmotic susceptibility of the cold-stored erythrocyte.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27756835" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : New insights on hereditary erythrocyte membrane defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20015879" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : Cryohydrocytosis: increased activity of cation carriers in red cells from a patient with a band 3 mutation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13762977" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : Stomatocytosis: a hereditary red cell anomally associated with haemolytic anaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29191841" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : PIEZO1-R1864H rare variant accounts for a genetic phenotype-modifier role in dehydrated hereditary stomatocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33570625" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : Piezo1-xerocytosis red cell metabolome shows impaired glycolysis and increased hemoglobin oxygen affinity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6324926" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : Red cell membrane and cation deficiency in Rh null syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9327782" id="rid153" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>154 : Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2757970" id="rid154" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>155 : Haemolytic anaemia in analpha-lipoproteinaemia (Tangier disease): morphological, biochemical, and biophysical properties of the red blood cell.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23310983" id="rid155" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>156 : Sitosterolemia's stomatocytosis and macrothrombocytopenia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24166850" id="rid156" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>157 : Specific macrothrombocytopenia/hemolytic anemia associated with sitosterolemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26256107" id="rid157" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>158 : Peripheral blood features of phytosterolaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/493871" id="rid158" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>159 : Acquired stomatocytosis in alcoholic liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5412483" id="rid159" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>160 : Transient stomatocytosis with hemolysis: a previously unrecognized complication of alcoholism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2741652" id="rid160" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>161 : A transient hemolytic reaction and stomatocytosis following vinca alkaloid administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1732016" id="rid161" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>162 : Mechanisms of amphipath-induced stomatocytosis in human erythrocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/149799" id="rid162" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>163 : Monovalent cation transport in irreversibly sickled cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5666109" id="rid163" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>164 : Irreversibly sickled erythrocytes: a consequence of the heterogeneous distribution of hemoglobin types in sickle-cell anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9679176" id="rid164" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>165 : Differential oxygen sensitivity of the K+-Cl- cotransporter in normal and sickle human red blood cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8326017" id="rid165" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>166 : Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8180398" id="rid166" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>167 : Adhesion of sickle cells to vascular endothelium is critically dependent on changes in density and shape of the cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3768533" id="rid167" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>168 : Vaso-occlusion by sickle cells: evidence for selective trapping of dense red cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1562742" id="rid168" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>169 : Red blood cell changes during the evolution of the sickle cell painful crisis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3998622" id="rid169" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>170 : Red cell distribution width parallels dense red cell disappearance during painful crises in sickle cell anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2810352" id="rid170" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>171 : Characteristics of the volume- and chloride-dependent K transport in human erythrocytes homozygous for hemoglobin C.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid171" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>172 : Hemoglobin C in transgenic mice with full mouse globin knockouts [abstract]</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26273436" id="rid172" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>173 : Infantile pyknocytosis, a rare cause of hemolytic anemia in newborns: report of two cases in twin girls and literature overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23253864" id="rid173" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>174 : Infantile pyknocytosis: an under-recognized form of neonatal hemolytic anemia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16643454" id="rid174" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>175 : Infantile pyknocytosis: a cause of haemolytic anaemia of the newborn.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
